Prefilled Syringes Market (6th Edition) by Therapeutic Area (Blood disorders, Infectious diseases, Metabolic disorders, Autoimmune disorders, Oncological disorders, Neurological disorders, Ophthalmic disorders and Other disorders), Type of Syringe (Specialty Syringes and Others) , Type of Material (Glass and Plastic), Type of Molecule (Antibody, Peptide, Protein, Small Molecule and Vaccine), and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and Africa and Rest of the World): Industry Trends and Global Forecasts, 2022-2035

  • Lowest Price Guaranteed From USD 5,899

  • Published
    May 2022

  • Pages
    911

  • View Count
    21555

Example Insights

Prefilled-Syringe-Market-6th-Edition-Context-thumb Prefilled-Syringe-Market-6th-Edition-List-of-developers-thumb Prefilled-Syringe-Market-6th-Edition-Distribution-by-Packaging-Volume-thumb Prefilled-Syringe-Market-6th-Edition-Product-Competitiveness-Analysis-thumb
Prefilled-Syringe-Market-6th-Edition-Recent-Initiatives-thumb Prefilled-Syringe-Market-6th-Edition-Patent-Analysis-thumb Prefilled-Syringe-Market-6th-Edition-Key-Opinion-Leaders-thumb Prefilled-Syringe-Market-6th-Edition-List-of-Combination-Products-thumb
Prefilled-Syringe-Market-6th-Edition-Distribution-by-Phase-of-Development-thumb Prefilled-Syringe-Market-6th-Edition-Case-Study-thumb Prefilled-Syringe-Market-6th-Edition-Big-Pharma-Initiatives-thumb Prefilled-Syringe-Market-6th-Edition-Approved-Drugs-thumb
Prefilled-Syringe-Market-6th-Edition-Potential-Strategic-Partners-thumb Prefilled-Syringe-Market-6th-Edition-Forecast-thumb Prefilled-Syringe-Market-6th-Edition-Opportunity-thumb  

 

Overview

We are seeing an increased demand in the emerging markets, particularly within the BRICS nations, namely Brazil, Russia, India, China and South Africa. North Africa and the Middle East also present a similar scenario, characterized by a growth rate of 10-18% for prefilled syringes

-- Marketing Director, a large-sized company

According to the World Health Organization (WHO), the prevalence of chronic diseases, such as heart diseases, cancers and diabetes, has increased at a steady pace in recent years. It is worth highlighting that six out of ten individuals in the US are anticipated to be suffering from at least one chronic disease. Specifically, such patients are required to take medication on a daily basis, necessitating frequent hospital visits. As per a recent study conducted by the US Centers for Disease Control (CDC), the annual expense incurred by patients suffering from such disease conditions has increased at a significant rate and is estimated to be USD 3 trillion. It is also worth highlighting that, with the onset of COVID-19 pandemic and the associated restrictions, patients are not able to visit hospitals. In order to mitigate the aforementioned challenges, companies engaged in the pharmaceutical domain have developed self-administrable dosage forms to ease out the overall treatment process. In this context, it is important to mention that the rise in global population and shortage of healthcare facilities has paved the way for a wider adoption of self-administrable dosage forms, such as prefilled syringes, among the patients.

Prefilled syringes are regarded as one of the safest options amongst the available alternatives for the intravenous mode of administration, as they demonstrate increased ease of self-administration due to elimination of dosing errors, as well as minimize the time requirements. Further, these syringes serve as a primary drug container for various drug delivery systems, such as autoinjectors and pen-injectors. Presently, more than 110 drugs, in combination with prefilled syringes, are commercially available. Amongst these, close to 60% of the products target autoimmune disorders. However, the increase in demand for such self-administration solutions has led to more stringent safety regulations, resulting in an evident rise in the cost of safety systems / end products. To combat this challenge, many players are actively undertaking research initiatives focused on developing low-cost alternatives that can boost the penetration rate and uptake of prefilled syringes by the end users. We believe that the aforementioned developments are likely to fuel the ongoing innovation and growth of the prefilled syringes market in the foreseen future.

Scope of the Report

The Prefilled Syringes Market (6th Edition) by Therapeutic Area (Blood disorders, Infectious diseases, Metabolic disorders, Autoimmune disorders, Oncological disorders, Neurological disorders, Ophthalmic disorders and Other disorders), Type of Syringe (Specialty Syringes and Others) , Type of Material (Glass and Plastic), Type of Molecule (Antibody, Peptide, Protein, Small Molecule and Vaccine), and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and Africa and Rest of the World): Industry Trends and Global Forecasts, 2022-2035 report features an extensive study of the current market landscape and the likely future potential associated with the prefilled syringe market, over the next decade. The study also includes an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the report features:

  • A detailed overview of the current market landscape of players engaged in the manufacturing of prefilled syringes, based on several relevant parameters, such as year of establishment, company size, geographical location of the headquarters and manufacturing facilities, type of material used (glass and plastic), number of barrel chambers (single chamber and dual chamber), type of needle system (fixed needle system, luer lock and luer cone) and syringe volume. 
  • An overview of the current market landscape of companies engaged in the development of drugs in prefilled syringe format, based on several relevant parameters, such as year of establishment, company size, location of headquarters, target therapeutic area, phase of development, type of drug molecule, route of administration, approval year (for marketed products), dose strength (for marketed products) and other approved dosage forms (for marketed products). 
  • A detailed product competitiveness analysis of prefilled syringes, based on supplier power (in terms of employee count and annual revenues) and key product specifications (including number of chambers and needle systems, volume of the barrel and other distinguishing features).
  • An in-depth analysis of marketed drugs / therapies and pipeline candidates that are likely to be available in prefilled syringe format in the near future, based on several relevant parameters, such as route of administration, type of drug molecule, target indication, other available dosage forms (for approved drugs) and historical annual sales information (for approved drugs).
  • A list of nearly 80 drug developers that are likely to partner with prefilled syringe manufacturers (with regard to likely collaboration opportunities for combination product development). These players have been shortlisted based on various parameters, such as pipeline strength, target therapeutic indication(s) and developer strength.
  • A review of the various prefilled syringe combination product-related initiatives undertaken by big pharma players (shortlisted on the basis of revenues generated in 2020), based on various parameters, such as current adoption (based on number of approved and under development prefilled syringe combination products) and target therapeutic area(s) and type of drug molecule.
  • An analysis highlighting the key opinion leaders (KOLs) in this domain. It features a 2x2 analysis to assess the relative experience of certain KOLs, who were shortlisted based on their contributions (in terms of involvement in various trial studies, number of citations, number of publications and geographical location) in this field.
  • An in-depth analysis of patents related to prefilled syringes, filed / granted, since 2015, based on several relevant parameters, such as type of patent (granted patents and patent applications), publication year, geographical location, CPC symbols, emerging focus areas, most active players (in terms of the number of patents filed / granted). In addition, it features a patent valuation analysis which evaluates the qualitative and quantitative aspects of the patents. 
  • A detailed analysis of contract fill / finish services providers that offer services for prefilled syringes, featuring a list of active (large-sized) service providers and analysis based on a number of several relevant parameters, such as year of establishment, company size, scale of operation (preclinical, clinical and commercial), type of drug molecule (biologics and small molecules), and geographical location of the service provider. 
  • A detailed discussion on various safety features (add-on and integrated devices) installed in recent versions of prefilled syringes and the companies involved in developing and manufacturing such solutions.
  • An informative summary of various guidelines established and issued by major regulatory bodies for the approval of prefilled syringes, across different countries / geographical regions.  
  • A brief discussion on the currently available specialty syringes, including prefilled flush syringes, prefilled diluent syringe systems and prefilled contrast agent delivery systems, along with providing details related to the various advantages offered by such devices. 
  • A detailed case study of companies engaged in the manufacturing of autoinjectors, featuring brief profiles of key players in this domain; each profile includes an overview of the firm, and information on its respective product portfolio.
  • Elaborate profiles of prominent prefilled syringe manufacturers engaged in this domain, featuring a brief overview of the company, its financial information (if available), information on product portfolio, recent developments and an informed future outlook.
  • Elaborate profiles of prominent prefilled syringe component manufacturers, featuring a brief overview of the company, its financial information (if available), information on product portfolio, recent developments and an informed future outlook.

One of the key objectives of the report was to evaluate the current market size and the future opportunity within the prefilled syringes market. Based on various relevant parameters, such as number of commercialized combination products, annual adoption rate, and expected pricing. We have provided an informed estimate of the likely evolution of the market for the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented on the basis of  [A] therapeutic area (blood disorders, infectious diseases, metabolic disorders, autoimmune disorders, oncological disorders, neurological disorders, ophthalmic disorders and other disorders), [B] type of syringe (specialty syringe and others), [C] type of material (glass and plastic), [D] number of chambers (single chamber and dual chamber),  [E] type of drug molecule (antibodies, proteins, vaccines, small molecules, peptides, and others), and [F] key geographical regions (North America, Europe (the UK, France, Italy, Spain, Germany and the rest of Europe), Latin America (Brazil, Mexico, Argentina and the rest of Latin America), Asia Pacific (Japan, China, India, South Korea and the rest of Asia Pacific), and the Middle East and Africa (Saudi Arabia, UAE, Africa and the rest of the Middle East)). 

The research, analysis and insights presented in this report are backed by a deep understanding of key insights gathered from both secondary and primary research. The opinions and insights presented in the report were influenced by discussions held with several players in this industry. The study includes detailed transcripts of discussions held with the following individuals:

  • Matthew Young (Founder and Chief Technology Officer, Oval Medical Technologies)
  • Kirti Maheshwari (Chief Technical Officer, Intas Pharmaceuticals)
  • Gregor Kawaletz (Ex-Chief Commercial Officer, IDT Biologika)
  • Tibor Hlobik (Senior Director, Product Technology Services) and Kevin Cancelliere (Ex-Directors, Pharmaceutical Delivery Systems Marketing)
  • Marco Pederiva (Head of R&D and Product Strategy, Lonstroff)
  • Jesse Fourt (Design Director, IDEO) 
  • Anonymous (Chief Executive Officer, Small-sized Medical Device Company)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Key Questions Answered

  • Who are the key players engaged in the development of prefilled syringes and its components?
  • What are the most adopted configuration / attributes associated with the prefilled syringes? 
  • Which companies are actively engaged in offering fill / finish services for prefilled syringes?
  • What is the relative competitiveness of different prefilled syringes that are currently available / under development? 
  • What are the key recent initiatives undertaken by players engaged in the manufacturing of prefilled syringes? 
  • How has the overall patent landscape related to prefilled syringes evolved over the past few years?
  • What is the cost burden associated with the needlestick injuries and its preventions?
  • What is the regulatory landscape for the approval of prefilled syringes across different geographies? 
  • Which companies are actively engaged in the development of combination products using prefilled syringes?
  • What are the most prominent therapeutic areas being targeted by prefilled syringes?
  • Who are the key opinion leaders in this domain?
  • Which players are likely to partner with prefilled syringe developers in order to offer combination products?
  • What are the crucial factors that are driving the prefilled syringes market?
  • Which drugs are likely to be considered for administration in prefilled syringe format?
  • How is the current and future market opportunity likely to be distributed across key market segments?

Contents

Chapter Outlines

Chapter 2 is an executive summary of the insights captured in our research. It offers a high-level view on the likely evolution of the prefilled syringes market in the mid to long term.

Chapter 3 provides a general overview of the prefilled syringes, including details on their origin, various affiliated components (such as barrel, lock adapter, lubricant, needle, needle shield, plunger rod / piston, plunger stopper and tip cap), fabrication material (glass and plastic), manufacturing-related information, and other critical attributes and features. Further, it highlights the opportunities associated within this domain. 

Chapter 4 An overview of the current market landscape of players engaged in the manufacturing of prefilled syringes, based on several relevant parameters, such as year of establishment, company size, geographical location of the headquarters and manufacturing facilities, type of material used (glass and plastic), number of barrel chambers (single chamber and dual chamber), type of needle system (fixed needle system, luer lock and luer cone) and syringe volume.

Chapter 5 presents a detailed product competitiveness analysis of prefilled syringes, based on supplier power (in terms of employee count and annual revenues) and key product specifications (including number of chambers and needle systems, volume of the barrel and other distinguishing features).

Chapter 6 elaborates profiles of prominent prefilled syringe manufacturers engaged in this domain, featuring a brief overview of the company, its financial information (if available), information on product portfolio, recent developments and an informed future outlook.

Chapter 7 highlights the growing concerns associated with needlestick injuries and the various steps (including regional and global legislations) that have been taken to prevent sharps related mishaps. One of the important risk mitigation strategies covered in this chapter is the installation of safety features in upcoming versions of prefilled syringes. In addition, it provides a detailed discussion on various safety features (add-on and integrated devices) installed in recent versions of prefilled syringes and the companies engaged in development and manufacturing of such solutions.

Chapter 8 provides an informative summary of various guidelines established and issued by major regulatory bodies for the approval of prefilled syringes, across different countries / geographical regions.

Chapter 9 features a detailed analysis of the key opinion leaders engaged in this domain, based on various parameters, such as (number of clinical trials, number of citations, number of publications, research gate, geographical location of the institute and research gate score).

Chapter 10 features an in-depth analysis of patents related to prefilled syringes, filed / granted, since 2015, based on several relevant parameters, such as type of patent (granted patents and patent applications), publication year, geographical location, CPC symbols, emerging focus areas, most active players (in terms of the number of patents filed / granted). In addition, it features a patent valuation analysis which evaluates the qualitative and quantitative aspects of the patents.

Chapter 11 provides details on the various pipeline and approved products that are being evaluated or available in the form of prefilled syringes, primarily focusing on injectable drugs and vaccines. It features a detailed analysis of these drugs, based on various parameters, such as the target therapeutic area(s), phase of development, type of drug molecule, route of administration, approval year (in case of marketed products), dosage (in case of marketed products) and other approved dosage forms (in case of marketed products). In addition, the chapter provides information on drug developers engaged in this domain, along with information on their year of establishment, location of headquarters and manufacturing facilities, and strength of employee base. The chapter also includes case studies of top two marketed drugs available in prefilled syringes, namely Humira® and Enbrel®. 

Chapter 12 features a discussion on the most commonly targeted therapeutic indications, including information on the approved / marketed injectable drug products available for the treatment of such clinical conditions (across different target therapeutic areas) and their respective biosimilars.

Chapter 13 presents an in-depth analysis of marketed drugs / therapies and pipeline candidates that are likely to be available in prefilled syringe format in the near future, based on several relevant parameters, such as route of administration, type of drug molecule, target indication, other available dosage forms (for approved drugs) and historical annual sales information (for approved drugs). Additionally, the chapter features an insightful analysis, highlighting potential strategic partners (primarily drug developers) for prefilled syringes manufacturers, based on multiple parameters, such as pipeline strength, targeted therapeutic indications, and developer strength. The analysis aims to provide the necessary inputs to the latter type of stakeholders, enabling them to make the right decisions to develop combination products.

Chapter 14 features a review of the various prefilled syringe combination product-related initiatives undertaken by big pharma players (shortlisted on the basis of revenue generated in 2020), based on various parameters, such as current adoption (based on number of approved and under development prefilled syringe combination products) and target therapeutic area(s) and type of drug molecule.

Chapter 15 features information on specialty syringes, namely prefilled flush syringes, prefilled diluent systems and prefilled contrast agent delivery systems. For each type of specialty syringe, we have provided a brief overview and details on the different products that are available in the market and their advantages.

Chapter 16 discusses the recent technological developments in this domain and their applications. The chapter provides details on the advancements in design technology and manufacturing of prefilled syringes that have enabled pharmaceutical companies to market lyophilized drugs in dual chambered syringe systems. The chapter also highlights novel lubrication and sterilization technologies.

Chapter 17 presents an insightful market forecast analysis, highlighting the future potential of the prefilled syringes market till the year 2035. Our year-wise projections of the current and future opportunity have further been segmented on the basis of  [A] therapeutic area (blood disorders, infectious diseases, metabolic disorders, autoimmune disorders, oncological disorders, neurological disorders, ophthalmic disorders and other disorders), [B] type of syringe (specialty syringes and other syringes), [C] type of material (glass and plastic), [D] number of chambers (single chamber and dual chamber),  [E] type of drug molecule (antibodies, proteins, vaccines, small molecules, peptides, and others), and [F] key geographical regions (North America, Europe (the UK, France, Italy, Spain, Germany and the rest of Europe), Latin America (Brazil, Mexico, Argentina and the rest of Latin America), Asia Pacific (Japan, China, India, South Korea and the rest of Asia Pacific), and the Middle East and Africa (Saudi Arabia, UAE, Africa and the rest of the Middle East)).

Chapter 18 features a detailed discussion on the various factors that are anticipated to drive growth within the prefilled syringes market, such as the rise in preference for self-administration of medication, increase in incidence of chronic diseases, evolving patient landscape, introduction and growing adoption of biologics / biosimilars, initiatives focused on the prevention of needlestick injuries and the various potential applications of prefilled syringes. 

Chapter 19 provides a detailed SWOT analysis of the prefilled syringes market. The chapter presents strategic insights on major factors that have contributed to the growth of the market, while highlighting the weaknesses and threats that are likely to have an impact on its future. 

Chapter 20 Elaborate profiles of prominent prefilled syringe component manufacturers, featuring a brief overview of the company, its financial information (if available), information on product portfolio, recent developments and an informed future outlook.

Chapter 21 A detailed analysis of contract fill / finish services providers that offer services for prefilled syringes, featuring a list of active (large-sized) service providers and analysis based on a number of several relevant parameters, such as year of establishment, company size, scale of operation (preclinical, clinical and commercial), type of drug molecule (biologics and small molecules), and geographical location of the service provider. 

Chapter 22 A detailed case study of companies engaged in the manufacturing of autoinjectors, featuring brief profiles of key players in this domain; each profile includes an overview of the firm, and information on its respective product portfolio.

Chapter 23 is a summary of the overall report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.

Chapter 24 is a collection of transcripts of interviews conducted with representatives from renowned organizations that are engaged in the prefilled syringes manufacturing domain. In this chapter, we have presented the details of our conversations with Matthew Young (Founder and Chief Technology Officer, Oval Medical Technologies), Kirti Maheshwari (Chief Technical Officer, Intas Pharmaceuticals), Gregor Kawaletz (Ex-Chief Commercial Officer, IDT Biologika), Kevin Cancelliere (Senior Directors, Product Technology Services) and Tibor Hlobik (Ex-Directors, Pharmaceutical Delivery Marketing System), Marco Pederiva (Marketing & Sales Director, Lonstroff) and Anonymous (Chief Executive Officer, Small-sized Medical Device Company). 

Chapters 25 is an appendix that provides tabulated data and numbers for all the figures included in the report.

Chapter 26 is an appendix that contains the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Chapter Overview
1.2. Scope of the Report
1.3. Research Methodology
1.4 Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY
2.1 Chapter Overview

3. INTRODUCTION
3.1. Chapter Overview
3.2. History of Prefilled Syringes
3.3. Benefits of Prefilled Syringes Over Traditional Injectable Devices
3.3.1. Benefits of Prefilled Syringes for Healthcare Professionals and End Users
3.3.2. Benefits of Prefilled Syringes for Manufacturers
3.3.3. Transition from Existing Dosage Forms to Prefilled Syringes

3.4. Prefilled Syringe Components
3.5. Classification of Prefilled Syringes
3.5.1. Classification by Barrel Fabrication Material
3.5.1.1. Glass Barrel Prefilled Syringes
3.5.1.1.1. Limitations of Glass Barrel Prefilled Syringes
3.5.1.1.2. Addressing the Limitations of Glass Barrel Prefilled Syringes

3.5.1.2. Plastic Barrel Prefilled Syringes
3.5.1.2.1. Limitations of Plastic Barrel Prefilled Syringes
3.5.1.2.2. Addressing the Limitations of Plastic Barrel Prefilled Syringes
3.5.1.2.3. Factors Likely to Drive the Use of Plastic Prefilled Syringes

3.5.2. Classification based on Number of Chambers in the Barrel 
3.5.3. Classification based on Type of Needle
3.5.4. Classification based on Type of Packaging

3.6. Critical Attributes of Prefilled Syringe Design
3.7. Key Manufacturing Steps for Prefilled Syringes
3.7.1. Production of Barrels
3.7.1.1. Glass Barrels
3.7.1.2. Plastic Barrels

3.7.2. Production of Syringes
3.7.3. Barrel Siliconization
3.7.4. Syringe Sterilization
3.7.5. Validation of Sterilization 
3.7.6. Syringe Filling
3.7.7. Syringe Testing 
3.8. Future Perspectives

4. PREFILLED SYRINGES: MARKET OVERVIEW
4.1. Chapter Overview
4.2. Prefilled Syringes: List of Available / Under Development Devices
4.2.1. Analysis by Type of Barrel Fabrication Material
4.2.2. Analysis by Number of Barrel Chambers
4.2.3. Analysis by Type of Needle System
4.2.4. Analysis by Device Capacity

4.3. Prefilled Syringes: List of Developers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Company Size and Location of Headquarters
4.3.5. Analysis by Location of Manufacturing Facilities
4.3.6. Most Active Players: Analysis by Number of Products
4.4. Technological Developments Related to Prefilled Syringes

5. PRODUCT COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions / Key Parameters
5.3. Methodology
5.4. Product Competitiveness Analysis: Prefilled Syringes 
5.4.1. Glass Barrel Prefilled Syringes
5.4.2. Plastic Barrel Prefilled Syringes

6. PREFILLED SYRINGE MANUFACTURERS
6.1. Chapter Overview
6.2. Key Prefilled Syringe Manufacturers Based in North America
6.2.1. Becton Dickinson (BD)
6.2.1.1. Company Overview
6.2.1.2. Financial Performance
6.2.1.3. BD Prefilled Technology Solutions

6.2.1.4. Glass Prefilled Systems
6.2.1.4.1. BD Hypak Prefilled Syringe
6.2.1.4.2. BD Neopak Prefilled Syringe
6.2.1.4.3. BD Hylok Prefilled Syringe

6.2.1.5. Plastic Prefilled Systems
6.2.1.5.1. BD Sterifill Syringe Systems
6.2.1.5.2 BD PosiFlush Syringe Systems
6.2.1.6. Other Prefilled Delivery Systems
6.2.1.6.1. BD Uniject
6.2.1.7. Future Outlook

6.2.2 Pfizer Hospital
6.2.2.1. Company Overview
6.2.2.2. Financial Performance
6.2.2.3 Prefilled Syringe Portfolio
6.2.2.3.1. ABBOJECT Syringe
6.2.2.3.2. Emergency Syringe
6.2.2.3.3. iSecure Syringe System
6.2.2.3.4. NEXJECT Syringe
6.2.2.4. Future Outlook
6.2.3. West Pharmaceutical
6.2.3.1. Company Overview
6.2.3.2. Financial Performance
6.2.3.3. Prefilled Technology Solutions
6.2.3.4. Plastic Prefilled Systems
6.2.3.4.1. Daikyo Crystal Zenith Polymer Ready-To-Use Prefilled Syringe
6.2.3.4.2 Drug Reconstitution Systems
6.2.3.4.3 History of CZ Syringe
6.2.4.5. Key Developments
6.2.4.6. Future Outlook

6.3. Key Prefilled Syringe Manufacturers Based in Europe
6.3.1. Gerresheimer
6.3.1.1. Company Overview
6.3.1.2. Financial Performance
6.3.1.3. Prefilled Technology Solutions
6.3.1.4. Glass Prefilled Systems
6.3.1.4.1. Gx Glass Syringes
6.3.1.5. Plastic Prefilled Systems
6.3.1.5.1. ClearJect Prefilled syringes
6.3.1.5.2. Gx RTF Clearject Needle Syringe
6.3.1.6. Safety Syringes
6.3.1.6.1. Gx InnoSafe Safety Syringes
6.3.1.7. Self-Injection Devices
6.3.1.8. Key Developments
6.3.1.8.1. Expansion of Product Portfolio
6.3.1.8.2 Expansion of Capacity of Medical Plastic Systems
6.3.1.9. Future Outlook

6.3.2. Ompi
6.3.2.1. Company Overview
6.3.2.2. Financial Performance
6.3.2.3. Glass Prefilled Systems
6.3.2.3.1. EZ-fill Syringes
6.3.2.3.1.1. EZ-fill Fina
6.3.2.3.1.2. EZ-fill Nexa
6.3.2.3.1.3. EZ-fill Alba
6.3.2.4. Key Developments
6.3.2.4.1. New Corporate Branding and Appointments
6.3.2.4.1. Capacity Expansion Across the Glass Divisions
6.3.2.4.1. Twist-Off Closure System for Prefilled Syringes
6.3.2.5. Future Outlook

6.3.3. Schott
6.3.3.1. Company Overview
6.3.3.2. Financial Performance
6.3.3.3. Glass Prefilled Syringes
6.3.3.3.1. syriQ Glass Syringes
6.3.3.4. Plastic Prefilled Syringes
6.3.3.4.1. TopPac Polymer Syringes
6.3.3.5. Product Portfolio
6.3.3.5.1. SyriQ BioPure Syrigne System for Sensitive Drugs
6.3.3.5.2. TopPac Syringe System for Sensitive Drugs
6.3.3.5.3. TopPac Syringe System for Highly Viscous Drugs
6.3.3.5.4. TopPac 20mL Syringe System for Infusion Therapy
6.3.3.5.5. Rebranding the Glass Prefilled Syringes
6.3.3.5.6. New Closure Systems for Plastic / Glass Prefilled System
6.3.3.6. Key Developments
6.3.3.6.1. Growth in Pharma Emerging Markets (Brazil, China, India, Indonesia, and Russia)
6.3.3.6.2. Expansion of Production Facilities in the US and EU
6.3.3.7. Future Outlook

6.4. Key Prefilled Syringe Manufacturers in Asia
6.4.1. Nipro 
6.4.1.1. Company Overview
6.4.1.2. Financial Performance
6.4.1.3. Glass Prefilled Systems
6.4.1.4. Key Developments
6.4.1.5. Future Outlook
6.4.2. Taisei Kako
6.4.2.1. Company Overview
6.4.2.2. Glass Prefilled Systems
6.4.2.2.1. VF-Syringe
6.4.2.2.2. SIN-Syringe
6.4.2.3. Plastic Prefilled System
6.4.2.3.1. ClearJect Syringes
6.4.2.3.2. FULJECT Passive Type Syringe
6.4.2.4. Future Outlook

6.5. Other Manufacturers
6.5.1. Aguettant
6.5.1.1. Company Overview
6.5.1.2. Prefilled Syringe Portfolio
6.5.1.2.1. Aguettant Prefilled Syringe
6.5.1.3. Key Developments
6.5.1.4. Future Outlook

6.5.2. Arte
6.5.2.1. Company Overview
6.5.2.2. Prefilled Syringe Portfolio
6.5.2.2.1. ARTE Pre-fillable Syringe
6.5.2.2.2. Dual Chamber Prefilled Syringe
6.5.2.2.3. Single Chamber Pre-fillable Syringe
6.5.2.3. Future Outlook

6.5.3. J.O. Pharma (Subsidiary of Otsuka)
6.5.3.1. Company Overview
6.5.3.2. Prefilled Syringe Portfolio
6.5.3.3. Key Developments
6.5.3.4 Future Outlook

6.5.4. Shandong Pharmaceutical Glass
6.5.4.1. Company Overview
6.5.4.2. Prefilled Syringes Portfolio
6.5.4.3 Future Outlook

6.5.5. Shandong Zibo Minkang Pharmaceutical packing
6.5.5.1. Company Overview
6.5.5.2. Prefilled Syringes Portfolio
6.5.5.3. Future Outlook

6.5.6. Terumo
6.5.6.1. Company Overview
6.5.6.2. Financial Performance
6.5.6.3. PLAJEX (Plastic Prefilled Syringe)
6.5.6.4. Safety Devices: Add-On Devices
6.5.6.5. Key Developments
6.5.6.6. Future Outlook

6.5.7. Vetter Pharma
6.5.7.1. Company Overview
6.5.7.2. Prefilled Syringe Portfolio
6.5.7.2.1. Lyo-Ject Glass Prefilled Syringe
6.5.7.2.2. Vetter-Ject Safety Device
6.5.7.2.3. V-OVS Safety Device
6.5.7.3. Key Developments
6.5.7.4. Future Outlook

6.5.8. Shangdong WEGO Prefills Pharmaceutical Packaging
6.5.8.1. Company Overview
6.5.8.2. Financial Performance
6.5.8.3. Shandong Wego Glass Prefilled Syringe
6.5.8.4. Wego Prefilled Flush Syringes
6.5.8.5. Future Outlook

7. NEEDLESTICK INJURIES
7.1. Chapter Overview
7.2. Incidence and Associated Financial Burden
7.3. Government Legislations for Prevention of Needlestick Injuries
7.4. Safety Mechanisms used in Modern Prefilled Syringes
7.4.1. Safety Systems: Add-On Safety Device Manufacturers
7.4.1.1. Becton Dickinson
7.4.1.2. Catalent
7.4.1.3. Terumo
7.4.1.4. Tip-Top
7.4.1.5. West Pharmaceutical

7.4.2. Safety Systems: Integrated Safety Device Manufacturers
7.4.2.1. Gerresheimer
7.4.2.2. Injecto
7.4.2.3. MedicalChain International
7.4.2.4. Ompi
7.4.2.5. Owen Mumford
7.4.2.6. SHL Group
7.4.2.7. Taisei Kako

8. REGULATORY LANDSCAPE FOR PREFILLED SYRINGES
8.1. Chapter Overview
8.1.1. Regulatory Approval of Combination Products in the US
8.1.2. Overview
8.1.3. Historical Background
8.1.4. Regulatory Bodies in Product Approval
8.1.5. Role of Regulatory Approval for Prefilled Syringes
8.1.5.1. Reimbursement Landscape
8.1.5.2. Payer Mix
8.1.5.3. Reimbursement Process

8.2. Regulatory Approval of Combination Products in Europe
8.2.1. Overview
8.2.2. Role of Regulatory Bodies in Product Approval
8.2.3. Regulatory Approval for Prefilled Syringes

8.2.3.1. Reimbursement Landscape for the UK
8.2.3.2. Payer Mix
8.2.3.3. Reimbursement Process in the UK

8.2.3.4. Reimbursement Landscape for France
8.2.3.5. Payer Mix
8.2.3.6. Reimbursement Process in France

8.2.3.7. Reimbursement Landscape for Spain
8.2.3.8. Payer Mix
8.2.3.9. Reimbursement Process in Spain

8.2.3.10. Reimbursement Landscape for Germany
8.2.3.11. Payer Mix
8.2.3.12. Reimbursement Process in Germany

8.2.3.13. Reimbursement Landscape for Italy
8.2.3.14. Payer Mix
8.2.3.15. Reimbursement Process in Italy

8.3. Regulatory Approval of Combination Products in Canada
8.3.1. Overview
8.3.2. Role of Regulatory Bodies in Product Approval
8.3.3. Regulatory Approval for Prefilled Syringes 
8.3.3.1. Reimbursement Landscape for Canada
8.3.3.2. Payer Mix
8.3.3.3. Reimbursement Process in Canada

8.4. Regulatory Approval of Combination Products in Brazil
8.4.1. Overview
8.4.2. Role of Regulatory Bodies in Product Approval
8.4.3. Regulatory Approval for Prefilled Syringes 
8.4.3.1. Reimbursement Landscape for Brazil
8.4.3.1.1. Payer Mix
8.4.3.2.1. Reimbursement Process in Brazil

8.5. Regulatory Approval of Combination Products in Australia
8.5.1. Overview
8.5.2. Role of Regulatory Bodies in Product Approval
8.5.3. Regulatory Approval for Prefilled Syringes 
8.5.3.1. Reimbursement Landscape for Australia
8.5.3.1.1. Payer Mix
8.5.3.1.2. Reimbursement Process in Australia

8.6. Regulatory Approval of Combination Products in Japan
8.6.1. Overview
8.6.2. Role of Regulatory Bodies in Product Approval
8.6.3. Regulatory Approval for Prefilled Syringes 
8.6.3.1. Reimbursement Landscape for Japan
8.6.3.1.1 Payer Mix
8.6.3.1.2 Reimbursement Process in Japan

8.7. Regulatory Approval of Combination Products in China
8.7.1. Overview
8.7.2. Role of Regulatory Bodies in Product Approval
8.7.3. Regulatory Approval for Prefilled syringes 
8.7.3.1. Reimbursement Landscape for China
8.7.3.1.1. Payer Mix
8.7.3.1.2. Reimbursement Process in China

8.8. Regulatory Approval of Combination Products in India
8.8.1. Overview
8.8.2. Role of Regulatory Bodies in Product Approval
8.8.3. Regulatory Approval for Prefilled Syringes 
8.8.3.1. Reimbursement Landscape for India
8.8.3.1.1. Payer Mix

8.9. Regulatory Approval of Combination Products in South Korea
8.9.1. Overview
8.9.2. Role of Regulatory Bodies in Product Approval
8.9.3. Regulatory Approval for Prefilled Syringes 
8.9.3.1. Reimbursement Landscape for South Korea
8.9.3.1.1. Payer Mix
8.9.3.1.2. Reimbursement Process in South Korea

8.10. Regulatory Approval of Combination Products in Saudi Arabia
8.10.1. Overview
8.10.2. Role of Regulatory Bodies in Product Approval
8.10.3.1. Reimbursement Landscape for Saudi Arabia
8.10.3.1.1. Payer Mix
8.10.3.1.2. Reimbursement Process in Saudi Arabia

8.11. Regulatory Approval of Combination Products in United Arab Emirates
8.11.1. Overview
8.11.2. Role of Regulatory Bodies in Product Approval
8.11.3. Regulatory Approval for Prefilled Syringes 
8.11.3.1. Reimbursement Landscape for United Arab Emirates
8.11.3.1.1 Reimbursement Process in United Arab Emirates

9. PREFILLED SYRINGE COMBINATION PRODUCTS 
9.1. Chapter Overview
9.2. Prefilled Syringe Combination Products: List of Approved Drugs
9.2.1. Analysis by Type of Drug Molecule
9.2.2. Analysis by Approval Year 
9.2.3. Analysis by Geography
9.2.4. Analysis by Route of Administration 
9.2.5. Analysis by Target Therapeutic Area
9.2.6. Prefilled Syringe Combination Products: Additional Information
9.2.6.1. Information on Dose Strength
9.2.6.2. Analysis by Other Approved Dosage Forms

9.3. Prefilled Syringe Combination Products: List of Clinical Stage Drugs
9.3.1. Analysis by Type of Drug Molecule 
9.3.2. Analysis by Phase of Development 
9.3.3. Analysis by Route of Administration
9.3.4. Analysis by Target Therapeutic Area
9.4. Prefilled Syringe Combination Products: List of Developers
9.4.1. Analysis by Year of Establishment
9.4.2. Analysis by Company Size
9.4.3. Analysis by Location of Headquarters

9.5. Leading Drugs in Prefilled Syringe Format
9.6. Other Drugs Available in Prefilled Syringe Format

9.7. Case Study of Popular Drugs Available in Prefilled Syringe Market
9.7.1. HUMIRA (Adalimumab), AbbVie / Eisai
9.7.1.1. Target Indications and Available Dosage Forms
9.7.1.2. Shift from Vials to Prefilled Syringes
9.7.2. Enbrel (Etanercept), Amgen / Pfizer / Takeda
9.7.2.1. Target Indications and Available Dosage Forms
9.7.2.2. Shift from Vials to Syringes

10. KEY THERAPEUTIC AREAS
10.1. Chapter Overview
10.1.1. Autoimmune Disorders
10.1.1.1. Approved Injectables
10.1.1.2. Biosimilars

10.1.2. Infectious Diseases
10.1.2.1. Anti-Viral Drugs
10.1.2.1.1. Approved Drugs
10.1.2.1.2. Biosimilars
10.1.3. Vaccines
10.1.3.1. Approved Injectables

10.1.4. Neurological Disorders
10.1.4.1. Approved Injectables
10.1.4.2. Biosimilars

10.1.5. Metabolic Disorders
10.1.5.1. Approved Injectables
10.1.5.2. Biosimilars

11. PREFILLED SYRINGES: LIKELY DRUG CANDIDATES AND PARTNER ANALYSIS
11.1. Chapter Overview
11.2. Likely Drug Candidates
11.2.1. Methodology and Key Parameters

11.3. Marketed Drug Candidates
11.3.1. Most Likely Candidates for Delivery via Prefilled Syringes
11.3.2. Likely Candidates for Delivery via Prefilled Syringes
11.3.3. Less Likely Candidates for Delivery via Prefilled Syringes
11.3.4. Least Likely Candidates for Delivery via Prefilled Syringes

11.4. Clinical Stage Drug Candidates
11.4.1. Most Likely Candidates for Delivery via Prefilled Syringes
11.4.2. Likely Candidates for Delivery via Prefilled Syringes
11.4.3. Less Likely Candidates for Delivery via Prefilled Syringes
11.4.4. Least Likely Candidates for Delivery via Prefilled Syringes

11.5. Potential Strategic Partner
11.5.1. Methodology and Key Parameters
11.5.2. Potential Strategic Partners in North America
11.5.2.1. Most Likely Partners for Prefilled Syringes Combination Products
11.5.2. 2. Likely Partners for Prefilled Syringes Combination Products
11.5.2.3. Less Likely Partners for Prefilled Syringes Combination Products
11.5.2.4. Least Likely Partners for Prefilled Syringes Combination Products

11.5.3. Potential Strategic Partners in Europe
11.5.3.1. Most Likely Partners for Prefilled Syringes Combination Products
11.5.3.2. Likely Partners for Prefilled Syringes Combination Products
11.5.3.3. Less Likely Partners for Prefilled Syringes Combination Products
11.5.3.4. Least Likely Partners for Prefilled Syringes Combination Products

11.5.4. Potential Strategic Partners in Asia-Pacific and Rest of the World
11.5.4.1. Most Likely Partners for Prefilled Syringes Combination Products
11.5.4.2. Likely Partners for Prefilled Syringes Combination Products
11.5.4.3. Less Likely Partners for Prefilled Syringes Combination Products

12. BIG PHARMA INITIATIVES: PREFILLED SYRINGE COMBINATION PRODUCTS
12.1. Chapter Overview
12.2. Methodology
12.2.1 Top Pharmaceutical Companies
12.2.2. Analysis by Therapeutic Area
12.2.2.1. Autoimmune Disorders
12.2.2.2. Infectious Diseases
12.2.2.3. Oncological Disorders
12.2.2.4. Metabolic Disorders
12.2.2.5. Neurological Disorders

12.2.3. Analysis by Type of Molecule
12.2.3.1. Antibodies
12.2.3.2. Vaccines
12.2.3.3. Proteins

13. RECENT DEVELOPMENTS
13.1. Chapter Overview
13.2. List of Recent Initiatives Related to Prefilled Syringes, 2019-2021
13.3. Analysis by Year of Initiative
13.4. Analysis by Type of Initiative
13.5. Analysis by Year and Type of Initiative
13.5.1. Analysis by Type of Expansion
13.5.2. Analysis by Type of Partnership
13.6. Analysis by Geography
13.7. Most Active Players: Distribution by Number of Initiatives
13.8. Analysis of Player by Type of Initiatives

14. PATENT ANALYSIS
14.1 Chapter Overview
14.2. Patent Analysis: Prefilled Syringes
14.2.1. Scope and Methodology
14.2.2. Analysis by Publication Year
14.2.3. Analysis by Publication Year and Type of Patent
14.2.4. Analysis by Geography
14.2.4.1. Patent Analysis: North America Scenario
14.2.4.2. Patent Analysis: Europe Scenario
14.2.4.3. Patent Analysis: Asia-Pacific Scenario
14.2.5. Analysis by CPC Symbols
14.2.6. Most Active Players: Analysis by Number of Patents
14.2.7. Key Inventors: Analysis by Number of Patents
14.2.8. Patent Benchmarking Analysis
14.2.8.1. Analysis by Patent Characteristics
14.2.9. Patent Analysis: Analysis by Type of Organization
14.2.10. Patent Valuation Analysis

15. KOL ANALYSIS
15.1. Chapter Overview
15.2 Prefilled Syringes: Key Opinion Leaders
15.3 Analysis by Geographical Location of KOLs
15.4. Most Prominent Institutes: Analysis by Number of KOLs
15.5. KOL Activeness v/s KOL Strength
15.6. Most Prominent KOLs: Analysis by RA Score
15.7. Most Prominent KOLs: Comparison of RA Score with Third Party Score

16. SPECIALTY PREFILLED SYRINGES
16.1. Chapter Overview
16.2. Prefilled Flush Syringes
16.2.1. Overview
16.2.2. Prefilled Flush Syringes Available in the Market
16.2.3. Advantages of Prefilled Flush Syringes

16.3. Prefilled Diluent Syringes
16.3.1. Overview
16.3.2. Lyophilized Drugs Available in Prefilled Diluent Syringes
16.3.3. Advantages of Prefilled Diluent Syringes

16.4. Contrast Agent Prefilled Syringes
16.4.1. Overview
16.4.2. Contrast Agents Available in Prefilled Syringes
16.4.3. Advantages of Using Prefilled Syringes for Contrast Agents 

17. TECHNOLOGICAL ADVANCES RELATED TO PREFILLED SYRINGE
17.1. Chapter Overview
17.2. Prefilled Syringes for Lyophilized Drugs
17.2.1. Prefilled Diluent Syringes
17.2.2. Prefilled Dual / Multi-Chamber Prefilled Syringes
17.2.2.1. Lyophilized Drugs Available in Dual-Chamber Prefilled Pen Injectors

17.3. Prefilled Syringes for Ophthalmic Delivery
17.4. Prefilled Syringes for Dermal Fillers
17.5. Multilayer Plastic Prefilled Syringes with Oxygen Barrier
17.6. Prefilled Syringes with Low Risk of Particle Formation 
17.7. Lubrication Technology for Prefilled Syringes

17.8. Advances in Terminal Sterilization of Prefilled Syringes
17.8.1. Noxilizer’s Nitrogen Dioxide Sterilization Technology
17.9. Prefilled Syringe Usage Aids for Patients and Healthcare Providers

18. MARKET SIZING AND OPPORTUNITY ANALYSIS
18.1. Chapter Overview
18.2. Scope and Methodology
18.3. Global Prefilled Syringes Market, 2022-2035
18.3.1. Prefilled Syringes Market: Distribution by Therapeutic Area
18.3.1.1. Prefilled Syringes Market for Autoimmune Disorders, 2022-2035
18.3.1.2. Prefilled Syringes Market for Infectious Diseases, 2022-2035
18.3.1.3. Prefilled Syringes Market for Neurological Disorders, 2022-2035
18.3.1.4. Prefilled Syringes Market for Blood Disorders, 2022-2035
18.3.1.5. Prefilled Syringes Market for Oncological Disorders, 2022-2035
18.3.1.6. Prefilled Syringes Market for Psychiatric Diseases, 2022-2035
18.3.1.7. Prefilled Syringes Market for Respiratory Disorders, 2022-2035
18.3.1.8. Prefilled Syringes Market for Cardiovascular Disorders, 2022-2035
18.3.1.9. Prefilled Syringes Market for Metabolic Disorders, 2022-2035
18.3.1.10. Prefilled Syringes Market for Ophthalmic Disorder, 2022-2035
18.3.1.11. Prefilled Syringes Market for Orthopedic Disorders, 2022-2035
18.3.1.12. Prefilled Syringes Market for Other Diseases, 2022-2035

18.3.2. Prefilled Syringes Market: Analysis by Type of Syringe Barrel Material
18.3.2.1. Prefilled Syringes Market for Glass Barrel Prefilled Syringes, 2022-2035
18.3.2.2. Prefilled Syringes Market for Plastic Barrel Prefilled Syringes, 2022-2035

18.3.3. Prefilled Syringes Market: Analysis by Type of Chamber System
18.3.3.1. Prefilled Syringes Market for Single Chamber Prefilled Syringes, 2022-2035
18.3.3.2. Prefilled Syringes Market for Dual Chamber Prefilled Syringes, 2022-2035

18.3.4. Prefilled Syringes Market: Analysis by Type of Drug Molecule
18.3.4.1. Prefilled Syringes Market for Antibodies, 2022-2035
18.3.4.2. Prefilled Syringes Market for Proteins, 2022-2035
18.3.4.3. Prefilled Syringes Market for Peptides, 2022-2035
18.3.4.4. Prefilled Syringes Market for Small Molecules, 2022-2035
18.3.4.5. Prefilled Syringes Market for Vaccines, 2022-2035
18.3.4.6. Prefilled Syringes Market for Cell Therapy, 2022-2035

18.3.5. Prefilled Syringes Market: Analysis by Geography
18.3.5.1. Prefilled Syringes Market for North America, 2022-2035
18.3.5.2. Prefilled Syringes Market for Europe, 2022-2035
18.3.5.3. Prefilled Syringes Market for Asia Pacific, 2022-2035
18.3.5.4. Prefilled Syringes Market for Latin America, 2022-2035
18.3.5.5. Prefilled Syringes Market for Middle East and Africa, 2022-2035

18.3.6. Prefilled Syringes Market: Analysis by Specialty Syringes
18.3.7. Prefilled Syringes Market for Autoimmune Disorders, 2022-2035
18.3.7.1. Prefilled Syringes Market for Autoimmune Disorders: Analysis by Syringe Barrel Material
18.3.7.1.1. Glass Barrel Prefilled Syringes Market for Autoimmune Disorders
18.3.7.1.2. Plastic Barrel Prefilled Syringes Market for Autoimmune Disorders
18.3.7.2. Prefilled Syringes Market for Autoimmune Disorders: Analysis by Type of Chamber System
18.3.7.2.1. Single Chamber Prefilled Syringes Market for Autoimmune Disorders
18.3.7.2.2. Dual Chamber Prefilled Syringes Market for Autoimmune Disorders
18.3.7.3. Prefilled Syringes Market for Autoimmune Disorders: Analysis by Type of Drug Molecule
18.3.7.3.1. Antibodies Market for Autoimmune Disorders
18.3.7.3.2. Proteins Market for Autoimmune Disorders
18.3.7.4. Prefilled Syringes Market for Autoimmune Disorders: Analysis by Geography
18.3.7.4.1. North America Market for Autoimmune Disorders
18.3.7.4.2. Europe Market for Autoimmune Disorders
18.3.7.4.3. Asia Pacific Market for Autoimmune Disorders
18.3.7.4.4. Latin America Market for Autoimmune Disorders
18.3.7.4.5. Middle East and Africa Market for Autoimmune Disorders

18.3.8. Prefilled Syringes Market for Infectious Disorders, 2022-2035
18.3.8.1. Prefilled Syringes Market for Infectious Disorders: Analysis by Type of Syringe Barrel Material
18.3.8.1.1. Glass Barrel Prefilled Syringes Market for Infectious Disorders
18.3.8.1.2. Plastic Barrel Prefilled Syringes Market for Infectious Disorders
18.3.8.2. Prefilled Syringes Market for Infectious Disorders: Analysis by Type of Chamber System
18.3.8.2.1. Single Chamber Prefilled Syringes Market for Infectious Disorders
18.3.8.2.2. Dual Chamber Prefilled Syringes Market for Infectious Disorders
18.3.8.3. Prefilled Syringes Market for Infectious Disorders: Analysis by Type of Drug Molecule
18.3.8.3.1. Vaccines Market for Infectious Disorders
18.3.8.4. Prefilled Syringes Market for Infectious Disorders: Analysis by Geography
18.3.8.4.1. North America Market for Infectious Disorders
18.3.8.4.2. Europe Market for Infectious Disorders
18.3.8.4.3. Asia Pacific Market for Infectious Disorders
18.3.8.4.4. Latin America Market for Infectious Disorders
18.3.8.4.5. Middle East and Africa Market for Infectious Disorders

18.3.9. Prefilled Syringes Market for Neurological Disorders, 2022-2035
18.3.9.1. Prefilled Syringes Market for Neurological Disorders: Analysis by Type of Syringe Barrel Material
18.3.9.1.1. Glass Barrel Prefilled Syringes Market for Neurological Disorders
18.3.9.1.2. Plastic Barrel Prefilled Syringes Market for Neurological Disorders
18.3.9.2. Prefilled Syringes Market for Neurological Disorders: Analysis by Type of Chamber System
18.3.9.2.1. Single Chamber Prefilled Syringes Market for Neurological Disorders
18.3.9.2.2. Dual Chamber Prefilled Syringes Market for Neurological Disorders
18.3.9.3. Prefilled Syringes Market for Neurological Disorders: Analysis by Type of Drug Molecule
18.3.9.3.1. Antibodies Market for Neurological Disorders
18.3.9.4. Prefilled Syringes Market for Neurological Disorders: Analysis by Geography
18.3.9.4.1. North America Market for Neurological Disorders
18.3.9.4.2. Europe Market for Neurological Disorders
18.3.9.4.3. Asia Pacific Market for Neurological Disorders
18.3.9.4.4. Latin America Market for Neurological Disorders
18.3.9.4.5. Middle East and Africa Market for Neurological Disorders

18.3.10. Prefilled Syringes Market for Blood Disorders, 2022-2035
18.3.10.1. Prefilled Syringes Market for Blood Disorders: Analysis by Type of Syringe Barrel Material
18.3.10.1.1. Glass Barrel Prefilled Syringes Market for Blood Disorders
18.3.10.1.2. Plastic Barrel Prefilled Syringes Market for Blood Disorders
18.3.10.2. Prefilled Syringes Market for Blood Disorders: Analysis by Type of Chamber System
18.3.10.2.1. Single Chamber Prefilled Syringes Market for Blood Disorders
18.3.10.2.2. Dual Chamber Prefilled Syringes Market for Blood Disorders
18.3.10.3. Prefilled Syringes Market for Blood Disorders: Analysis by Type of Drug Molecule
18.3.10.3.1. Proteins Market for Blood Disorders
18.3.10.4. Prefilled Syringes Market for Blood Disorders: Analysis by Geography
18.3.10.4.1. North America Market for Blood Disorders
18.3.10.4.2. Europe Market for Blood Disorders
18.3.10.4.3. Asia Pacific Market for Blood Disorders
18.3.10.4.4. Latin America Market for Blood Disorders
18.3.10.4.5. Middle East and Africa Market for Blood Disorders

18.3.11. Prefilled Syringes Market for Oncological Disorders, 2022-2035
18.3.11.1. Prefilled Syringes Market for Oncological Disorders: Analysis by Type of Syringe Barrel Material
18.3.11.1.1. Glass Barrel Prefilled Syringes Market for Oncological Disorders
18.3.11.1.2. Plastic Barrel Prefilled Syringes Market for Oncological Disorders
18.3.11.2. Prefilled Syringes Market for Oncological Disorders: Analysis by Type of Chamber System
18.3.11.2.1. Single Chamber Prefilled Syringes Market for Oncological Disorders
18.3.11.2.2. Dual Chamber Prefilled Syringes Market for Oncological Disorders
18.3.11.3. Prefilled Syringes Market for Oncological Disorders: Analysis by Type of Drug Molecule
18.3.11.3.1. Antibodies Market for Oncological Disorders
18.3.11.3.2. Proteins Market for Oncological Disorders
18.3.11.4. Prefilled Syringes Market for Oncological Disorders: Analysis by Geography
18.3.11.4.1. North America Market for Oncological Disorders
18.3.11.4.2. Europe Market for Oncological Disorders
18.3.11.4.3. Asia Pacific Market for Oncological Disorders
18.3.11.4.4. Latin America Market for Oncological Disorders
18.3.11.4.5. Middle East and Africa Market for Oncological Disorders

18.3.12. Prefilled Syringes Market for Metabolic Disorders, 2022-2035
18.3.12.1. Prefilled Syringes Market for Metabolic Disorders: Analysis by Type of Syringe Barrel Material
18.3.12.1.1. Glass Barrel Prefilled Syringes Market for Metabolic Disorders
18.3.12.1.2. Plastic Barrel Prefilled Syringes Market for Metabolic Disorders
18.3.12.2. Prefilled Syringes Market for Metabolic Disorders: Analysis by Type of Chamber System
18.3.12.2.1. Single Chamber Prefilled Syringes Market for Metabolic Disorders
18.3.12.2.2. Dual Chamber Prefilled Syringes Market for Metabolic Disorders
18.3.12.3. Prefilled Syringes Market for Metabolic Disorders: Analysis by Type of Drug Molecule
18.3.12.3.1. Peptides Market for Metabolic Disorders
18.3.12.4. Prefilled Syringes Market for Metabolic Disorders: Analysis by Geography
18.3.12.4.1. North America Market for Metabolic Disorders
18.3.12.4.2. Europe Market for Metabolic Disorders
18.3.12.4.3. Asia Pacific Market for Metabolic Disorders
18.3.12.4.4. Latin America Market for Metabolic Disorders
18.3.12.4.5. Middle East and Africa Market for Metabolic Disorders

18.3.13. Prefilled Syringes Market for Respiratory Disorders, 2022-2035
18.3.13.1. Prefilled Syringes Market for Respiratory Disorders: Analysis by Type of Syringe Barrel Material
18.3.13.1.1. Glass Barrel Prefilled Syringes Market for Respiratory Disorders
18.3.13.1.2. Plastic Barrel Prefilled Syringes Market for Respiratory Disorders
18.3.13.2. Prefilled Syringes Market for Respiratory Disorders: Analysis by Type of Chamber System
18.3.13.2.1. Single Chamber Prefilled Syringes Market for Respiratory Disorders
18.3.13.2.2. Dual Chamber Prefilled Syringes Market for Respiratory Disorders
18.3.13.3. Prefilled Syringes Market for Respiratory Disorders: Analysis by Type of Drug Molecule
18.3.13.3.1. Antibody Market for Respiratory Disorders
18.3.13.4. Prefilled Syringes Market for Respiratory Disorders: Analysis by Geography
18.3.13.4.1. North America Market for Respiratory Disorders
18.3.13.4.2. Europe Market for Respiratory Disorders
18.3.13.4.3. Asia Pacific Market for Respiratory Disorders
18.3.13.4.4. Latin America Market for Respiratory Disorders
18.3.13.4.5. Middle East and Africa Market for Respiratory Disorders

18.3.14. Prefilled Syringes Market for Cardiovascular Disorders, 2022-2035
18.3.14.1. Prefilled Syringes Market for Cardiovascular Disorders: Analysis by Type of Syringe Barrel Material
18.3.14.1.1. Glass Barrel Prefilled Syringes Market for Cardiovascular Disorders
18.3.14.1.2. Plastic Barrel Prefilled Syringes Market for Cardiovascular Disorders
18.3.14.2. Prefilled Syringes Market for Cardiovascular Disorders: Analysis by Type of Chamber System
18.3.14.2.1. Single Chamber Prefilled Syringes Market for Cardiovascular Disorders
18.3.14.2.2. Dual Chamber Prefilled Syringes Market for Cardiovascular Disorders
18.3.14.3. Prefilled Syringes Market for Cardiovascular Disorders: Analysis by Type of Drug Molecule
18.3.14.3.1. Cell Therapy Market for Cardiovascular Disorders
18.3.14.4. Prefilled Syringes Market for Cardiovascular Disorders: Analysis by Geography
18.3.14.4.1. North America Market for Cardiovascular Disorders
18.3.14.4.2. Europe Market for Cardiovascular Disorders
18.3.14.4.3. Asia Pacific Market for Cardiovascular Disorders
18.3.14.4.4. Latin America Market for Cardiovascular Disorders
18.3.14.4.5. Middle East and Africa Market for Cardiovascular Disorders

18.3.15. Prefilled Syringes Market for Ophthalmic Disorders, 2022-2035
18.3.15.1. Prefilled Syringes Market for Ophthalmic Disorders: Analysis by Type of Syringe Barrel Material
18.3.15.1.1. Glass Barrel Prefilled Syringes Market for Ophthalmic Disorders
18.3.15.1.2. Plastic Barrel Prefilled Syringes Market for Ophthalmic Disorders
18.3.15.2. Prefilled Syringes Market for Ophthalmic Disorders: Analysis by Type of Chamber System
18.3.15.2.1. Single Chamber Prefilled Syringes Market for Ophthalmic Disorders
18.3.15.2.2. Dual Chamber Prefilled Syringes Market for Ophthalmic Disorders
18.3.15.3. Prefilled Syringes Market for Ophthalmic Disorders: Analysis by Type of Drug Molecule
18.3.15.3.1. Antibody Market for Ophthalmic Disorders
18.3.15.3.2. Proteins Market for Ophthalmic Disorders
18.3.15.4. Prefilled Syringes Market for Ophthalmic Disorders: Analysis by Geography
18.3.15.4.1. North America Market for Ophthalmic Disorders
18.3.15.4.2. Europe Market for Ophthalmic Disorders
18.3.15.4.3. Asia Pacific Market for Ophthalmic Disorders
18.3.15.4.4. Latin America Market for Ophthalmic Disorders
18.3.15.4.5. Middle East and Africa Market for Ophthalmic Disorders

18.3.16. Prefilled Syringes Market for Orthopedic Disorders, 2022-2035
18.3.16.1. Prefilled Syringes Market for Orthopedic Disorders: Analysis by Type of Syringe Barrel Material
18.3.16.1.1. Glass Barrel Prefilled Syringes Market for Orthopedic Disorders
18.3.16.1.2. Plastic Barrel Prefilled Syringes Market for Orthopedic Disorders
18.3.16.2. Prefilled Syringes Market for Orthopedic Disorders: Analysis by Type of Chamber System
18.3.16.2.1. Single Chamber Prefilled Syringes Market for Orthopedic Disorders
18.3.16.2.2. Dual Chamber Prefilled Syringes Market for Orthopedic Disorders
18.3.16.3. Prefilled Syringes Market for Orthopedic Disorders: Analysis by Type of Drug Molecule
18.3.16.3.1. Antibodies Market for Orthopedic Disorders
18.3.16.3.2. Small Molecules Market for Orthopedic Disorders
18.3.16.3.3. Cell Therapy Market for Orthopedic Disorders
18.3.16.4. Prefilled Syringes Market for Orthopedic Disorders: Analysis by Geography
18.3.16.4.1. North America Market for Orthopedic Disorders
18.3.16.4.2. Europe Market for Orthopedic Disorders
18.3.16.4.3. Asia Pacific Market for Orthopedic Disorders
18.3.16.4.4. Latin America Market for Orthopedic Disorders
18.3.16.4.5. Middle East and Africa Market for Orthopedic Disorders

18.3.17. Prefilled Syringes Market for Other Disorders, 2022-2035
18.3.17.1. Prefilled Syringes Market for Other Disorders: Analysis by Type of Syringe Barrel Material
18.3.17.1.1. Glass Barrel Prefilled Syringes Market for Other Disorders
18.3.17.1.2. Plastic Barrel Prefilled Syringes Market for Other Disorders
18.3.17.2. Prefilled Syringes Market for Other Disorders: Analysis by Type of Chamber System
18.3.17.2.1. Single Chamber Prefilled Syringes Market for Other Disorders
18.3.17.2.2. Dual Chamber Prefilled Syringes Market for Other Disorders
18.3.17.3. Prefilled Syringes Market for Other Disorders: Analysis by Type of Drug Molecule
18.3.17.3.1. Antibodies Market for Other Disorders
18.3.17.3.2. Peptides Market for Other Disorders
18.3.17.3.3. Small Molecules Market for Other Disorders
18.3.17.3.4. Cell Therapy Market for Other Disorders
18.3.17.4. Prefilled Syringes Market for Other Disorders: Analysis by Geography
18.3.17.4.1. North America Market for Other Disorders
18.3.17.4.2. Europe Market for Other Disorders
18.3.17.4.3. Asia Pacific Market for Other Disorders
18.3.17.4.4. Latin America Market for Other Disorders
18.3.17.4.5. Middle East and Africa Market for Other Disorders

19. KEY GROWTH DRIVERS
19.1. Chapter Overview
19.2. Rising Incidence of Chronic Diseases
19.3. Growing Preference for Self-Injection
19.4. Evolving Patient Demographics
19.5. Growth of Biologics and Biosimilars Market
19.6. Changing Pharmaceutical Strategies
19.7. Increasing Focus on Prevention of Needlestick Injuries
19.8. Prefilled Syringes in Autoinjectors and Pen Injectors

20. SWOT ANALYSIS
20.1. Chapter Overview
20.2. Strengths
20.2.1. Ease of Use
20.2.2. Ability to Address Medication-related Errors
20.2.3. Reduction in Accidental Transmission of Blood-Borne Pathogens
20.2.4. Economic Advantages
20.2.5. Life Cycle Management

20.3. Weaknesses
20.3.1. Manufacturing Complexities
20.3.2. Elevated Packaging and Transportation Costs
20.3.3. Product Stability and Quality Challenges 
20.3.4. Challenges Associated with Drug Filing

20.4. Opportunities
20.4.1. Rich Pipeline of Drugs and Growth of Biologics / Biosimilars
20.4.2. Increase in Self-Injecting Patient Population
20.4.3. Application in Advanced Drug Delivery Devices
20.4.4. Innovation in Design and Other Technical Advancement
20.4.5. Rising Popularity across the Globe
20.4.6. Widespread Use in Vaccination Programs

20.5. Threats
20.5.1. Material Compatibility Issues
20.5.2. Availability of Alternative Drug Delivery Devices
20.5.3. Products Recalls in Recent Past

20.6. Concluding Remarks

21. PREFILLED SYRINGE COMPONENT MANUFACTURERS
21.1. Chapter Overview
21.2. List of Component Manufacturers
21.3. West Pharmaceutical
21.3.1. Company Overview
21.3.2. Financial Performance
21.3.3. Product Portfolio
21.3.4. Recent Developments and Future Outlook

21.4. Datwyler Sealing Solutions (a Part of Datwyler Group)
21.4.1. Company Overview
21.4.2. Financial Performance
21.4.3. Product Portfolio
21.4.4. Future Outlook
21.4.4. Recent Developments and Future Outlook

21.5. Aptar Pharma 
21.5.1. Company Overview
21.5.2. Financial Performance
21.5.3. Product Portfolio
21.5.4. Key Developments 
21.5.5. Recent Development and Future Outlook

21.6. Becton Dickinson
21.6.1. Company Overview
21.6.2. Financial Information
21.6.3. Product Portfolio
21.6.4. Recent Development and Future Outlook

21.7. Ompi (a Part of Stevanato Group)
21.7.1. Company Overview
21.7.2. Financial Information
21.7.3. Product Portfolio
21.7.4. Recent Developments and Future Outlook

21.8. Lonstroff (a Part of Sumitomo Rubber Industries)
21.8.1. Company Overview
21.8.2. Financial Performance
21.8.3. Product Portfolio
21.8.4. Key Developments 
21.8.5. Future Outlook

22. FILL / FINISH SERVICE PROVIDERS FOR PREFILLED SYRINGES
22.1. Chapter Overview
22.2. Fill / Finish Processing of Prefilled Syringes
22.2.1. Steps Involved in Fill / Finish Process
22.2.2. Methods of Filling and Stoppering of Prefilled Syringes
22.2.3. Prefilled Syringe Filling Technologies

22.3. Outsourcing Fill / Finish Operations
22.4. Growth Considerations
22.4.1. Recent Developments
22.5. Prefilled Syringes: List of Fill / Finish Service Providers
22.5.1. Analysis by Year of Establishment
22.5.2. Analysis by Type of Drug Molecule and Location of Headquarters 
22.5.3. Analysis by Scale of Operation 

23. CASE STUDY: AUTOINJECTORS
23.1. Chapter Overview
23.2. Market Overview of Autoinjectors

23.3. Key Players
23.3.1. Elcam Medical (E3D Elcam Drug Delivery Devices)
23.3.1.1. Company Overview
23.3.1.2. Product Portfolio
23.3.1.2. Autoinjector: Product Details
23.3.1.2.1.1. Flexi-Q Disposable Autoinjectors
23.3.1.2.1.2. Flexi-Q Disposable Autoinjectors

23.3.2. Owen Mumford
23.3.2.1. Company Overview
23.3.2.2. Product Portfolio
23.3.2.2.1 Autoinjectors: Product Details
23.3.2.2.1.1 Autoinjectors Micro
23.3.2.2.1.2. Autoinject 2
23.3.2.2.1.3. Autoinject Mini
23.3.2.2.1.4. Autoinject Visco
23.3.2.2.1.5. Unisafe Auto-injector
23.3.2.2.1.6. Unisafe Connected Auto-injector

23.3.4. SHL Group
23.3.4.1. Company Overview
23.3.4.2. Product Portfolio
23.3.4.2.1. Two-Step Disposable Autoinjectors: Product Portfolio
23.3.4.2.1.1. Amber (Pushclick Technology)
23.3.4.2.1.2. Molly
23.3.4.2.1.3. Molly RNS
23.3.4.2.1.4. Molly 2.25
23.3.4.2.1.5. Rotaject
23.3.4.2.1.6. Bertha
23.3.4.2.1.7. DAI 2
23.3.4.2.1.8. Maggie

23.3.5. Union Medico
23.3.5.1. Company Overview
23.3.5.2. Product Portfolio
23.3.5.2.1. Autoinjectors: Product Details
23.3.5.2.1.1. 45? Autoinjectors
23.3.5.2.1.2. 45?/ S Autoinjectors
23.3.5.2.1.3. 45?/ M Autoinjectors
23.3.5.2.1.4. 45?/ R Autoinjectors
23.3.5.2.1.5. 90? Autoinjectors
23.3.5.2.1.6. 90?/ S Autoinjectors
23.3.5.2.1.7. 90?/ M Autoinjectors
23.3.5.2.1.8. 90?/ XL Autoinjectors
23.3.5.2.1.9. 90? Autoinjectors
23.3.5.2.1.10. SuperGrip Autoinjectors

23.3.6. Ypsomed
23.3.6.1. Company Overview
23.3.6.2. Financial Information
23.3.6.3. Product Portfolio
23.3.6.3.1. Autoinjectors: Product Details
23.3.6.3.1.1. YpsoMate, YpsoMate 2.25 and YpsoMate 2.25 Pro
23.3.6.3.1.2. VarioJect
23.3.6.3.1.3. LyoTwist Trio, LyoTwist Trio S, LyoTwist Vario and Lyo Twist Vario S

24. CONCLUDING REMARKS
24.1. Chapter Overview

25. INTERVIEW TRANSCRIPTS
25.1. Chapter Overview
25.2. Oval Medical Technologies
25.2.1. Company Snapshot
25.2.2. Interview Transcript: Matthew Young, Founder and Chief Technology Officer

25.3. Intas Pharmaceuticals
25.3.1. Company Snapshot
25.3.2. Interview Transcript: Kirti Maheshwari, Chief Technical Officer

25.4. IDT Biologika
25.4.1. Company Snapshot
25.4.2. Interview Transcript: Gregor Kawaletz, Ex-Chief Commercial Officer

25.5. West Pharmaceutical
25.5.1. Company Snapshot
25.5.2. Interview Transcript: Tibor Hlobik, Senior Director and Kevin Cancelliere, Ex-Director

25.6. Lonstroff
25.6.1. Company Snapshot
25.6.2. Interview Transcript: Marco Pederiva, Head of R&D and Product Strategy

25.7. IDEO
25.7.1. Company Snapshot
25.7.2. Interview Transcript: Jesse Fourt, Design Directors

25.8. Small-sized Medical Device Company
25.8.1. Interview Transcript: Anonymous, Chief Executive Officer

26. APPENDIX 1: TABULATED DATA

27. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: Prefilled Syringes Developer Landscape
Figure 2.2 Executive Summary: Prefilled Syringes Market Landscape
Figure 2.3 Executive Summary: Recent Developments
Figure 2.4 Executive Summary: Patent Analysis
Figure 2.5 Executive Summary: Combination Products Landscape
Figure 2.6 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Glass Barrel Prefilled Syringes: Advantages and Disadvantages
Figure 3.2 Plastic Barrel Prefilled Syringes: Advantages and Disadvantages
Figure 3.3 Critical Design Parameters of Prefilled Syringes
Figure 3.4 Prefilled Syringe Manufacturing: Processes Involved
Figure 4.1 Prefilled Syringes: Distribution by Type of Barrel Fabrication Material
Figure 4.2 Prefilled Syringes: Distribution by Number of Barrel Chambers
Figure 4.3 Prefilled Syringes: Distribution by Type of Needle System
Figure 4.4 Prefilled Syringes: Distribution by Device Capacity
Figure 4.5 Prefilled Syringe Developers: Distribution by Year of Establishment
Figure 4.6 Prefilled Syringe Developers: Distribution by Company Size
Figure 4.7 Prefilled Syringe Developers: Distribution by Location of Headquarters 
Figure 4.8 Prefilled Syringe Developers: Distribution by Company Size and Location of Headquarters
Figure 4.9 Prefilled Syringe Developers: Distribution by Location of Manufacturing Facilities
Figure 4.10 Most Active Players: Analysis by Number of Products
Figure 4.11 Technological Evolution of Prefilled Syringes
Figure 5.1 Product Competitiveness Analysis: Glass Barrel Prefilled Syringes
Figure 5.2 Product Competitiveness Analysis: Plastic Barrel Prefilled Syringes
Figure 6.1 BD Medical: Annual Revenues, 2013 - 2021 (USD Billion)
Figure 6.2 BD Medical: Distribution of Revenues by Business Segments (2021)
Figure 6.3 Pfizer Hospital: Annual Revenues, 2017 - 2021 (USD Million)
Figure 6.4 West Pharmaceutical: Annual Revenue, 2013 –2021 (USD Million)
Figure 6.5 West Pharmaceutical: Distribution of Revenues by Business Segments, 2021
Figure 6.6 West Pharmaceutical: Distribution of Revenues by Region, 2021
Figure 6.7 Gerresheimer: Annual Revenues, 2013 – 6M 2022 (EUR Million)
Figure 6.8 Gerresheimer: Distribution of Revenues by Business Divisions (2021) 
Figure 6.9 Gerresheimer: Regional Distribution of Revenues, 2021 
Figure 6.10 Stevanato: Annual Revenues, 2019 – 6M 2022 (EUR Million)
Figure 6.11 Stevanato: Distribution of Revenues by Business Segments (2021) 
Figure 6.12 Stevanato: Regional Distribution of Revenue (2021)
Figure 6.13 Schott: Annual Revenues, 2013–2021 (EUR Billion)
Figure 6.14 Schott: Regional Distribution of Revenues in 2021
Figure 6.15 Nipro: Annual Revenue, 2013-2022 (JPY Billion)
Figure 6.16 Nipro: Distribution of Revenue by Business Segment, 2022
Figure 6.17 Nipro: Regional Distribution of Revenue, 2022
Figure 6.18 Terumo: Annual Revenues, 2012 - 3M 2022 (JPY Billion)
Figure 6.19 Terumo: Distribution of Revenues by Business Divisions (2021)
Figure 6.20 Shandong Weigao: Annual Revenues, 2014 - 2021 (RMB Billion)
Figure 6.21 Shandong Weigao: Distribution of Revenue by Principal Products, 2021
Figure 6.22 Shandong Weigao: Distribution of Revenue by Region, 2021
Figure 7.1 Worldwide Evolution in Healthcare Safety Legislation
Figure 8.1 Global Regulations Related to Prefilled Syringes
Figure 8.2 Approval Pathway for Combination Products in the US
Figure 8.3 Healthcare Insurance Coverage in the US: Distribution by Type of Coverage
Figure 8.4 Prefilled Syringes National Coverage Determination Process in the US
Figure 8.5 Healthcare Insurance Coverage in the UK: Distribution by Type of Coverage
Figure 8.6 Reimbursement Process for Prefilled syringes in the UK
Figure 8.7 Healthcare Insurance Coverage in France: Distribution by Type of Coverage
Figure 8.8 Reimbursement Process for Prefilled syringes Through LPPR
Figure 8.9 Reimbursement Process for Prefilled syringes in Spain
Figure 8.10 Reimbursement Process for In-Patient Setting in Germany
Figure 8.11 Reimbursement Process for Out-Patient Care in Germany
Figure 8.12 Reimbursement Process for Prefilled syringes in Italy
Figure 8.13 Approval Pathway for Combination Products in Canada
Figure 8.14 Healthcare Insurance Coverage in Canada: Distribution by Type of Coverage
Figure 8.15 Reimbursement Process for Prefilled syringes in Brazil
Figure 8.16 Healthcare Insurance Coverage in Australia: Distribution by Type of Coverage
Figure 8.17 ` Pharmaceuticals and Prefilled syringes Agency: Review / Approval Process
Figure 8.18 Snapshot of the Regulatory and Reimbursement Process in Japan
Figure 8.19 Healthcare Insurance Coverage in Japan: Distribution by Type of Coverage
Figure 8.20 Reimbursement Process for New Prefilled syringes in Japan
Figure 8.21 Approval Pathway for Combination Products in China
Figure 8.22 Healthcare Insurance Coverage in China: Distribution by Type of Coverage
Figure 8.23 Reimbursement Approval Process for Prefilled syringes in Shanghai
Figure 8.24 Healthcare Insurance Coverage in South Korea: Distribution by Type of Coverage
Figure 8.25 Healthcare Insurance Coverage in Saudi Arabia: Distribution by Type of Coverage
Figure 9.1 Approved Prefilled Syringe Combination Products: Distribution by Type of Drug Molecule
Figure 9.2 Approved Prefilled Syringe Combination Products: Distribution by Approval Year
Figure 9.3 Approved Prefilled Syringe Combination Products: Distribution by Geography
Figure 9.4 Approved Prefilled Syringe Combination Products: Distribution by Route of Administration
Figure 9.5 Approved Prefilled Syringe Combination Products: Distribution by Target Therapeutic Area
Figure 9.6 Approved Prefilled Syringe Combination Products: Distribution by Other Dosage Forms
Figure 9.7 Clinical Stage Prefilled Syringe Combination Products: Distribution by Type of Drug Molecule
Figure 9.8 Clinical Stage Prefilled Syringe Combination Products: Distribution by Phase of Development
Figure 9.9 Clinical Stage Prefilled Syringe Combination Products: Distribution by Route of Administration
Figure 9.10 Clinical Stage Prefilled Syringe Combination Products: Distribution by Target Therapeutic Area
Figure 9.11 Prefilled Syringe Combination Product Developers: Distribution by Year of Establishment
Figure 9.12 Prefilled Syringe Combination Product Developers: Distribution by Company Size
Figure 9.13 Prefilled Syringe Combination Product Developers: Distribution by Location of Headquarters
Figure 9.14 Sales of Leading Drugs Available in Prefilled Syringes, 2021 (USD Billion)
Figure 9.15 HUMIRA®: Approval Timeline (US, EU and Japan)
Figure 9.16 HUMIRA®: Approval Timeline for Different Dosage Forms (US and EU)
Figure 9.17 HUMIRA®: Annual Sales, 2003 - 2021 (USD Million)
Figure 9.18 Enbrel®: Approval Timeline (US and EU)
Figure 9.19 Enbrel®: Approval Timeline for Different Dosage Forms (US and EU)
Figure 9.20 Enbrel®: Annual Sales, 2002-2021 (USD Million)
Figure 9.21 Enbrel®: Sales Outside the US, 2010-2021 (USD Million)
Figure 12.1 Big Pharma Initiatives: Distribution by Therapeutic Area
Figure 12.2 Big Pharma Initiatives for Autoimmune Disorders 
Figure 12.3 Big Pharma Initiatives for Autoimmune Disorders: Distribution by Target Indication
Figure 12.4 Big Pharma Initiatives for Infectious Diseases
Figure 12.5 Big Pharma Initiatives for Infectious Diseases: Distribution by Target Indication
Figure 12.6 Big Pharma Initiatives for Oncological Disorders 
Figure 12.7 Big Pharma Initiatives for Oncological Disorders: Distribution by Target Indication
Figure 12.8 Big Pharma Initiatives for Metabolic Disorders 
Figure 12.9 Big Pharma Initiatives for Metabolic Disorders: Distribution by Target Indication
Figure 12.10 Big Pharma Initiatives for Neurological Disorders 
Figure 12.11 Big Pharma Initiatives for Neurological Disorders: Distribution by Target Indication
Figure 12.12 Big Pharma Initiatives: Distribution by Type of Drug Molecule
Figure 12.13 Big Pharma Initiatives: Distribution by Antibodies
Figure 12.14 Big Pharma Initiatives: Distribution by Vaccines
Figure 12.15 Big Pharma Initiatives: Distribution by Proteins 
Figure 13.1 Recent Developments: Distribution by Year of Initiative
Figure 13.2 Recent Developments: Distribution by Type of Initiative
Figure 13.3 Recent Developments: Distribution by Year and Type of Initiative 
Figure 13.4 Recent Developments: Distribution by Type of Expansion
Figure 13.5 Recent Developments: Distribution by Location of Expansion
Figure 13.6 Recent Developments: Distribution by Focus Area of Expansion
Figure 13.7 Recent Developments: Distribution by Type of Partnership
Figure 13.8 Recent Developments: Distribution by Location of Headquarters
Figure 13.9 Most Active Players: Distribution by Number of Initiatives
Figure 13.10 Recent Developments: Distribution of Players by Type of Initiative
Figure 14.1 Patent Analysis: Distribution by Type of Patent
Figure 14.2 Patent Analysis: Cumulative Distribution by Publication Year, 2017-2021
Figure 14.3 Patent Analysis: Distribution by Publication Year and Type of Patent 
Figure 14.4 Patent Analysis: Distribution by Geography
Figure 14.5 Patent Analysis: Distribution by Year and Geography 
Figure 14.6 Patent Analysis: North America Scenario 
Figure 14.7 Patent Analysis: Europe Scenario 
Figure 14.8 Patent Analysis: Asia-Pacific Scenario 
Figure 14.9 Patent Analysis: Distribution by CPC Symbols
Figure 14.10 Most Active Players: Distribution by Number of Patents 
Figure 14.11 Key Inventors: Distribution by Number of Patents 
Figure 14.12 Patent Benchmarking Analysis: Leading Players
Figure 14.13 Patent Analysis: Distribution by Type of Organization
Figure 14.14 Patent Portfolio: Distribution by Patent Age
Figure 14.15 Patent Valuation Analysis
Figure 15.1 KOL Analysis: Distribution by Geographical Location
Figure 15.2 Most Prominent Institute: Distribution by Number of KOLs
Figure 15.3 Scatter Plot: KOL Activeness v/s KOL Strength
Figure 15.4 Most Prominent KOLs: Distribution by RA Score
Figure 15.5 Most Prominent KOLs: Comparison of RA Score with Third Party Score
Figure 15.6 Regression Analysis: Comparison of RA Score with Third-Party Score
Figure 18.1 Cost of Prefilled Syringes: Conservative, Base and Optimistic Scenarios, 2022-2035 (USD)
Figure18.2 Therapeutic Areas: Relative Share of Approved and Clinical Products with Prefilled Syringes
Figure 18.3 Global Prefilled Syringes Market, 2022-2035 (USD Million)
Figure 18.4 Prefilled Syringes Market: Distribution by Therapeutic Area, 2022 and 2035
Figure 18.5 Prefilled Syringes Market: Share of Autoimmune Disorders, 2022-2035 (USD Million)
Figure 18.6 Prefilled Syringes Market: Share of Infectious Diseases, 2022-2035 (USD Million)
Figure 18.7 Prefilled Syringes Market: Share of Neurological Disorders, 2022-2035 (USD Million)
Figure 18.8 Prefilled Syringes Market: Share of Blood Disorders, 2022-2035 (USD Million)
Figure 18.9 Prefilled Syringes Market: Share of Oncological Disorders, 2022-2035 (USD Million)
Figure 18.10 Prefilled Syringes Market: Share of Respiratory Disorders, 2022-2035 (USD Million)
Figure 18.11 Prefilled Syringes Market: Share of Cardiovascular Disorders, 2022-2035 (USD Million)
Figure 18.12 Prefilled Syringes Market: Share of Metabolic Disorders, 2022-2035 (USD Million)
Figure 18.13 Prefilled Syringes Market: Share of Ophthalmic Disorders, 2022-2035 (USD Million)
Figure 18.14 Prefilled Syringes Market: Share of Orthopedic Disorders, 2022-2035 (USD Million)
Figure 18.15 Prefilled Syringes Market: Share of Other Disorders, 2022-2035 (USD Million)
Figure 18.16 Prefilled Syringes Market: Distribution by Type of Syringe Barrel Material, 2022-2035
Figure 18.17 Prefilled Syringes Market: Share of Glass Barrel Prefilled Syringes, 2022-2035 (USD Million)
Figure 18.18 Prefilled Syringes Market: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (USD Million)
Figure 18.19 Prefilled Syringes Market: Distribution by Type of Chamber System, 2022 and 2035
Figure 18.20 Prefilled Syringes Market: Share of Single Chamber Syringes, 2022-2035 (USD Million)
Figure 18.21 Prefilled Syringes Market: Share of Dual Chamber Syringes, 2022-2035 (USD Million)
Figure 18.22 Prefilled Syringes Market: Distribution by Type of Drug Molecule, 2022-2035 (USD Million)
Figure 18.23 Prefilled Syringes Market: Share of Antibodies, 2022-2035 (USD Million)
Figure 18.24 Prefilled Syringes Market: Share of Proteins, 2022-2035 (USD Million)
Figure 18.25 Prefilled Syringes Market: Share of Peptides, 2022-2035 (USD Million)
Figure 18.26 Prefilled Syringes Market: Share of Small Molecules, 2022-2035 (USD Million)
Figure 18.27 Prefilled Syringes Market: Share of Vaccines, 2022-2035 (USD Million)
Figure 18.28 Prefilled Syringes Market: Share of Cell Therapy, 2022-2035 (USD Million)
Figure 18.29 Prefilled Syringes Market: Distribution by Geographical Regions (Million Units)
Figure 18.30 Prefilled Syringes Market: Distribution by Geographical Regions (USD Million)
Figure 18.31 Prefilled Syringes Market: Share of North America, 2022-2035 (Million Units)
Figure 18.32 Prefilled Syringes Market: Share of North America, 2022-2035 (USD Million)
Figure 18.33 Prefilled Syringes Market: Share of Europe, 2022-2035 (Million Units)
Figure 18.34 Prefilled Syringes Market: Share of Europe, 2022-2035 (USD Million)
Figure 18.35 Prefilled Syringes Market: Share of Asia Pacific, 2022-2035 (Million Unit)
Figure 18.36 Prefilled Syringes Market: Share of Asia Pacific, 2022-2035 (USD Million)
Figure 18.37 Prefilled Syringes Market: Share of Latin America, 2022-2035 (Million Units)
Figure 18.38 Prefilled Syringes Market: Share of Latin America, 2022-2035 (USD Million)
Figure 18.39 Prefilled Syringes Market: Share of Middle East and Africa, 2022-2035 (Million Units)
Figure 18.40 Prefilled Syringes Market: Share of Middle East and Africa, 2022-2035 (USD Million)
Figure 18.41 Prefilled Syringes Market: Distribution by Type of Syringe, (USD Million)
Figure 18.42 Prefilled Syringes Market: Share of Specialty Syringes, 2022-2035 (USD Million)
Figure 18.43 Prefilled Syringes Market: Share of Therapeutic Syringes, 2022-2035 (USD Million)
Figure 18.44 Prefilled Syringes Market for Autoimmune Disorders: Share of Glass Barrel Syringes, 2022-2035 (USD Million)
Figure 18.45 Prefilled Syringes Market for Autoimmune Disorders: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (USD Million)
Figure 18.46 Prefilled Syringes Market for Autoimmune Disorders: Share of Single Chamber Syringes, 2022-2035 (USD Million)
Figure 18.47 Prefilled Syringes Market for Autoimmune Disorders: Share of Dual Chamber Syringes, 2022-2035 (USD Million)
Figure 18.48 Prefilled Syringes Market for Autoimmune Disorders: Share of Antibodies, 2022-2035 (USD Million)
Figure 18.49 Prefilled Syringes Market for Autoimmune Disorders: Share of Proteins, 2022-2035 (USD Million)531
Figure 18.50 Prefilled Syringes Market for Autoimmune Disorders: Share of North America, 2022-2035 (Million Units)532
Figure 18.51 Prefilled Syringes Market for Autoimmune Disorders: Share of North America, 2022-2035 (USD Million)532
Figure 18.52 Prefilled Syringes Market for Autoimmune Disorders: Share of Europe, 2022-2035 (Million Units)
Figure 18.53 Prefilled Syringes Market for Autoimmune Disorders: Share of Europe, 2022-2035 (USD Million)
Figure 18.54 Prefilled Syringes Market for Autoimmune Disorders: Share of Asia Pacific, 2022-2035 (Million Units)
Figure 18.55 Prefilled Syringes Market for Autoimmune Disorders: Share of Asia Pacific, 2022-2035 (USD Million)
Figure 18.56 Prefilled Syringes Market for Autoimmune Disorders: Share of Latin America, 2022-2035 (Million Units)
Figure 18.57 Prefilled Syringes Market for Autoimmune Disorders: Share of Latin America, 2022-2035 (USD Million)
Figure 18.58 Prefilled Syringes Market for Autoimmune Disorders: Share of Middle East and Africa, 2022-2035 (Million Units)
Figure 18.59 Prefilled Syringes Market for Autoimmune Disorders: Share of Middle East and Africa, 2022-2035 (USD Million)
Figure 18.60 Prefilled Syringes Market for Infectious diseases: Share of Glass Barrel Syringes, 2022-2035 (USD Million)
Figure 18.61 Prefilled Syringes Market for Infectious Diseases: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (USD Million)
Figure 18.62 Prefilled Syringes Market for Infectious Diseases: Share of Single Chamber Syringes, 2022-2035 (USD Million)
Figure 18.63 Prefilled Syringes Market for Infectious Diseases: Share of Dual Chamber Syringes, 2022-2035 (USD Million)
Figure 18.64 Prefilled Syringes Market for Infectious Diseases: Share of Vaccine, 2022-2035 (USD Million)
Figure 18.65 Prefilled Syringes Market for Infectious Diseases: Share of North America, 2022-2035 (Million Units)
Figure 18.66 Prefilled Syringes Market for Infectious diseases: Share of North America, 2022-2035 (USD Million)
Figure 18.67 Prefilled Syringes Market for Infectious Diseases: Share of Europe, 2022-2035 (Million Units)
Figure 18.68 Prefilled Syringes Market for Infectious Diseases: Share of Europe, 2022-2035 (USD Million)
Figure 18.69 Prefilled Syringes Market for Infectious Diseases: Share of Asia Pacific, 2022-2035 (Million Units)
Figure 18.70 Prefilled Syringes Market for Infectious Diseases: Share of Asia Pacific, 2022-2035 (USD Million)
Figure 18.71 Prefilled Syringes Market for Infectious Diseases: Share of Latin America, 2022-2035 (Million Units)
Figure 18.72 Prefilled Syringes Market for Infectious Diseases: Share of Latin America, 2022-2035 (USD Million)
Figure 18.73 Prefilled Syringes Market for Infectious Diseases: Share of Middle East and Africa, 2022-2035 (Million Units)
Figure 18.74 Prefilled Syringes Market for Infectious diseases: Share of Middle East and Africa, 2022-2035 (USD Million)
Figure 18.75 Prefilled Syringes Market for Neurological Disorders: Share of Glass Barrel Syringes, 2022-2035 (USD Million)
Figure 18.76 Prefilled Syringes Market for Neurological Disorders: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (USD Million)
Figure 18.77 Prefilled Syringes Market for Neurological Disorders: Share of Single Chamber Syringes, 2022-2035 (USD Million)
Figure 18.78 Prefilled Syringes Market for Neurological Disorders: Share of Dual Chamber Syringes, 2022-2035 (USD Million)
Figure 18.79 Prefilled Syringes Market for Neurological Disorders: Share of Antibodies, 2022-2035 (USD Million)
Figure 18.80 Prefilled Syringes Market for Neurological Disorders: Share of North America, 2022-2035 (Million Units)
Figure 18.81 Prefilled Syringes Market for Neurological Disorders: Share of North America, 2022-2035 (USD Million)
Figure 18.82 Prefilled Syringes Market for Neurological Disorders: Share of Europe, 2022-2035 (Million Units)
Figure 18.83 Prefilled Syringes Market for Neurological Disorders: Share of Europe, 2022-2035 (USD Million)
Figure 18.84 Prefilled Syringes Market for Neurological Disorders: Share of Asia Pacific, 2022-2035 (Million Units)
Figure 18.85 Prefilled Syringes Market for Neurological Disorders: Share of Asia Pacific, 2022-2035 (USD Million)
Figure 18.86 Prefilled Syringes Market for Neurological Disorders: Share of Latin America, 2022-2035 (Million Units)
Figure 18.87 Prefilled Syringes Market for Neurological Disorders: Share of Latin America, 2022-2035 (USD Million)
Figure 18.88 Prefilled Syringes Market for Neurological Disorders: Share of Middle East and Africa, 2022-2035 (Million Units)
Figure 18.89 Prefilled Syringes Market for Neurological Disorders: Share of Middle East and Africa, 2022-2035 (USD Million)
Figure 18.90 Prefilled Syringes Market for Blood disorders: Share of Glass Barrel Syringes, 2022-2035 (USD Million)
Figure 18.91 Prefilled Syringes Market for Blood disorders: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (USD Million)
Figure 18.92 Prefilled Syringes Market for Blood Disorders: Share of Single Chamber Syringes, 2022-2035 (USD Million)
Figure 18.93 Prefilled Syringes Market for Blood Disorders: Share of Dual Chamber Syringes, 2022-2035 (USD Million)
Figure 18.94 Prefilled Syringes Market for Blood Disorders: Share of Proteins, 2022-2035 (USD Million)
Figure 18.95 Prefilled Syringes Market for Blood Disorders: Share of North America, 2022-2035 (Million Units)
Figure 18.96 Prefilled Syringes Market for Blood disorders: Share of North America, 2022-2035 (USD Million)
Figure 18.97 Prefilled Syringes Market for Blood Disorders: Share of Europe, 2022-2035 (Million Units)
Figure 18.98 Prefilled Syringes Market for Blood Disorders: Share of Europe, 2022-2035 (USD Million)
Figure 18.99 Prefilled Syringes Market for Blood disorders: Share of Asia Pacific, 2022-2035 (Million Units)
Figure 18.100 Prefilled Syringes Market for Blood disorders: Share of Asia Pacific, 2022-2035 (USD Million)
Figure 18.101 Prefilled Syringes Market for Blood disorders: Share of Latin America, 2022-2035 (Million Units)
Figure 18.102 Prefilled Syringes Market for Blood disorders: Share of Latin America, 2022-2035 (USD Million)
Figure 18.103 Prefilled Syringes Market for Blood disorders: Share of Middle East and Africa, 2022-2035 (Million Units)
Figure 18.104 Prefilled Syringes Market for Blood disorders: Share of Middle East and Africa, 2022-2035 (USD Million)
Figure 18.105 Prefilled Syringes Market for Oncological disorders: Share of Glass Barrel Syringes, 2022-2035 (USD Million)
Figure 18.106 Prefilled Syringes Market for Oncological disorders: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (USD Million)
Figure 18.107 Prefilled Syringes Market for Oncological disorders: Share of Single Chamber Syringes, 2022-2035 (USD Million)
Figure 18.108 Prefilled Syringes Market for Oncological disorders: Share of Dual Chamber Syringes, 2022-2035 (USD Million)
Figure 18.109 Prefilled Syringes Market for Oncological disorders: Share of Antibodies, 2022-2035 (USD Million)
Figure 18.110 Prefilled Syringes Market for Oncological disorders: Share of Proteins, 2022-2035 (USD Million)
Figure 18.111 Prefilled Syringes Market for Oncological disorders: Share of North America, 2022-2035 (Million Units)
Figure 18.112 Prefilled Syringes Market for Oncological disorders: Share of North America, 2022-2035 (USD Million)
Figure 18.113 Prefilled Syringes Market for Oncological disorders: Share of Europe, 2022-2035 (Million Units)
Figure 18.114 Prefilled Syringes Market for Oncological disorders: Share of Europe, 2022-2035 (USD Million)
Figure 18.115 Prefilled Syringes Market for Oncological disorders: Share of Asia Pacific, 2022-2035 (Million Units)
Figure 18.117 Prefilled Syringes Market for Oncological disorders: Share of Asia Pacific, 2022-2035 (USD Million)
Figure 18.118 Prefilled Syringes Market for Oncological disorders: Share of Latin America, 2022-2035 (Million Units)
Figure 18.119 Prefilled Syringes Market for Oncological disorders: Share of Latin America, 2022-2035 (USD Million)
Figure 18.120 Prefilled Syringes Market for Oncological disorders: Share of Middle East and Africa, 2022-2035 (Million Units)
Figure 18.121 Prefilled Syringes Market for Oncological disorders: Share of Middle East and Africa, 2022-2035 (USD Million)
Figure 18.122 Prefilled Syringes Market for Metabolic disorders: Share of Glass Barrel Syringes, 2022-2035 (USD Million)
Figure 18.123 Prefilled Syringes Market for Metabolic disorders: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (USD Million)
Figure 18.124 Prefilled Syringes Market for Metabolic disorders: Share of Single Chamber Syringes, 2022-2035 (USD Million)
Figure 18.125 Prefilled Syringes Market for Metabolic disorders: Share of Dual Chamber Syringes, 2022-2035 (USD Million)
Figure 18.126 Prefilled Syringes Market for Metabolic disorders: Share of Peptides, 2022-2035 (USD Million)
Figure 18.127 Prefilled Syringes Market for Metabolic disorders: Share of North America, 2022-2035 (Million Units)
Figure 18.128 Prefilled Syringes Market for Metabolic disorders: Share of North America, 2022-2035 (USD Million)
Figure 18.129 Prefilled Syringes Market for Metabolic disorders: Share of Europe, 2022-2035 (Million Units)
Figure 18.130 Prefilled Syringes Market for Metabolic disorders: Share of Europe, 2022-2035 (USD Million)
Figure 18.131 Prefilled Syringes Market for Metabolic disorders: Share of Asia Pacific, 2022-2035 (Million Units)
Figure 18.132 Prefilled Syringes Market for Metabolic disorders: Share of Asia Pacific, 2022-2035 (USD Million)
Figure 18.133 Prefilled Syringes Market for Metabolic disorders: Share of Latin America, 2022-2035 (Million Units)
Figure 18.134 Prefilled Syringes Market for Metabolic disorders: Share of Latin America, 2022-2035 (USD Million)
Figure 18.135 Prefilled Syringes Market for Metabolic disorders: Share of Middle East and Africa, 2022-2035 (Million Units)
Figure 18.136 Prefilled Syringes Market for Metabolic disorders: Share of Middle East and Africa, 2022-2035 (USD Million)
Figure 18.137 Prefilled Syringes Market for Respiratory disorders: Share of Glass Barrel Syringes, 2022-2035 (USD Million)
Figure 18.138 Prefilled Syringes Market for Respiratory disorders: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (USD Million)
Figure 18.139 Prefilled Syringes Market for Respiratory disorders: Share of Single Chamber Syringes, 2022-2035 (USD Million)
Figure 18.140 Prefilled Syringes Market for Respiratory disorders: Share of Dual Chamber Syringes, 2022-2035 (USD Million)
Figure 18.141 Prefilled Syringes Market for Respiratory disorders: Share of Antibody, 2022-2035 (USD Million)
Figure 18.142 Prefilled Syringes Market for Respiratory disorders: Share of North America, 2022-2035 (Million Units)
Figure 18.143 Prefilled Syringes Market for Respiratory disorders: Share of North America, 2022-2035 (USD Million)
Figure 18.144 Prefilled Syringes Market for Respiratory disorders: Share of Europe, 2022-2035 (Million Units)
Figure 18.145 Prefilled Syringes Market for Respiratory disorders: Share of Europe, 2022-2035 (USD Million)
Figure 18.146 Prefilled Syringes Market for Respiratory disorders: Share of Asia Pacific, 2022-2035 (Million Units)
Figure 18.147 Prefilled Syringes Market for Respiratory disorders: Share of Asia Pacific, 2022-2035 (USD Million)
Figure 18.148 Prefilled Syringes Market for Respiratory disorders: Share of Latin America, 2022-2035 (Million Units)
Figure 18.149 Prefilled Syringes Market for Respiratory disorders: Share of Latin America, 2022-2035 (USD Million)
Figure 18.150 Prefilled Syringes Market for Respiratory disorders: Share of Middle East and Africa, 2022-2035 (Million Units)
Figure 18.151 Prefilled Syringes Market for Respiratory disorders: Share of Middle East and Africa, 2022-2035 (USD Million)
Figure 18.152 Prefilled Syringes Market for Cardiovascular disorders: Share of Glass Barrel Syringes, 2022-2035 (USD Million)
Figure 18.153 Prefilled Syringes Market for Cardiovascular disorders: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (USD Million)
Figure 18.154 Prefilled Syringes Market for Cardiovascular disorders: Share of Single Chamber Syringes, 2022-2035 (USD Million)
Figure 18.155 Prefilled Syringes Market for Cardiovascular disorders: Share of Dual Chamber Syringes, 2022-2035 (USD Million)
Figure 18.156 Prefilled Syringes Market for Cardiovascular disorders: Share of Cell Therapy, 2022-2035 (USD Million)
Figure 18.157 Prefilled Syringes Market for Cardiovascular disorders: Share of North America, 2022-2035 (Million Units)
Figure 18.158 Prefilled Syringes Market for Cardiovascular disorders: Share of North America, 2022-2035 (USD Million)
Figure 18.159 Prefilled Syringes Market for Cardiovascular disorders: Share of Europe, 2022-2035 (Million Units)
Figure 18.160 Prefilled Syringes Market for Cardiovascular disorders: Share of Europe, 2022-2035 (USD Million)
Figure 18.161 Prefilled Syringes Market for Cardiovascular disorders: Share of Asia Pacific, 2022-2035 (Million Units)
Figure 18.162 Prefilled Syringes Market for Cardiovascular disorders: Share of Asia Pacific, 2022-2035 (USD Million)
Figure 18.163 Prefilled Syringes Market for Cardiovascular disorders: Share of Latin America, 2022-2035 (Million Units)
Figure 18.164 Prefilled Syringes Market for Cardiovascular disorders: Share of Latin America, 2022-2035 (USD Million)
Figure 18.165 Prefilled Syringes Market for Cardiovascular disorders: Share of Middle East and Africa, 2022-2035 (Million Units)
Figure 18.166 Prefilled Syringes Market for Cardiovascular disorders: Share of Middle East and Africa, 2022-2035 (USD Million)
Figure 18.167 Prefilled Syringes Market for Ophthalmic disorders: Share of Glass Barrel Syringes, 2022-2035 (USD Million)
Figure 18.168 Prefilled Syringes Market for Ophthalmic disorders: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (USD Million)
Figure 18.169 Prefilled Syringes Market for Ophthalmic disorders: Share of Single Chamber Syringes, 2022-2035 (USD Million)
Figure 18.170 Prefilled Syringes Market for Ophthalmic disorders: Share of Dual Chamber Syringes, 2022-2035 (USD Million)
Figure 18.171 Prefilled Syringes Market for Ophthalmic disorders: Share of Antibody, 2022-2035 (USD Million)
Figure 18.172 Prefilled Syringes Market for Ophthalmic disorders: Share of Proteins, 2022-2035 (USD Million)
Figure 18.173 Prefilled Syringes Market for Ophthalmic disorders: Share of North America, 2022-2035 (Million Units)
Figure 18.174 Prefilled Syringes Market for Ophthalmic disorders: Share of North America, 2022-2035 (USD Million)
Figure 18.175 Prefilled Syringes Market for Ophthalmic disorders: Share of Europe, 2022-2035 (Million Units)
Figure 18.176 Prefilled Syringes Market for Ophthalmic disorders: Share of Europe, 2022-2035 (USD Million)
Figure 18.177 Prefilled Syringes Market for Ophthalmic disorders: Share of Asia Pacific, 2022-2035 (Million Units)
Figure 18.178 Prefilled Syringes Market for Ophthalmic disorders: Share of Asia Pacific, 2022-2035 (USD Million)
Figure 18.179 Prefilled Syringes Market for Ophthalmic disorders: Share of Latin America, 2022-2035 (Million Units)
Figure 18.180 Prefilled Syringes Market for Ophthalmic disorders: Share of Latin America, 2022-2035 (USD Million)
Figure 18.181 Prefilled Syringes Market for Ophthalmic disorders: Share of Middle East and Africa, 2022-2035 (Million Units)
Figure 18.182 Prefilled Syringes Market for Ophthalmic disorders: Share of Middle East and Africa, 2022-2035 (USD Million)
Figure 18.183 Prefilled Syringes Market for Orthopedic disorders: Share of Glass Barrel Syringes, 2022-2035 (USD Million)
Figure 18.184 Prefilled Syringes Market for Orthopedic disorders: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (USD Million)
Figure 18.185 Prefilled Syringes Market for Orthopedic disorders: Share of Single Chamber Syringes, 2022-2035 (USD Million)
Figure 18.186 Prefilled Syringes Market for Orthopedic disorders: Share of Dual Chamber Syringes, 2022-2035 (USD Million)
Figure 18.187 Prefilled Syringes Market for Orthopedic disorders: Share of Antibodies, 2022-2035 (USD Million)
Figure 18.188 Prefilled Syringes Market for Orthopedic disorders: Share of Small Molecules, 2022-2035 (USD Million)
Figure 18.189 Prefilled Syringes Market for Orthopedic disorders: Share of Cell Therapy, 2022-2035 (USD Million)
Figure 18.190 Prefilled Syringes Market for Orthopedic disorders: Share of North America, 2022-2035 (Million Units)
Figure 18.191 Prefilled Syringes Market for Orthopedic disorders: Share of North America, 2022-2035 (USD Million)
Figure 18.192 Prefilled Syringes Market for Orthopedic disorders: Share of Europe, 2022-2035 (Million Units)
Figure 18.193 Prefilled Syringes Market for Orthopedic disorders: Share of Europe, 2022-2035 (USD Million)
Figure 18.194 Prefilled Syringes Market for Orthopedic disorders: Share of Asia Pacific, 2022-2035 (Million Units)
Figure 18.195 Prefilled Syringes Market for Orthopedic disorders: Share of Asia Pacific, 2022-2035 (USD Million)
Figure 18.196 Prefilled Syringes Market for Orthopedic disorders: Share of Latin America, 2022-2035 (Million Units)
Figure 18.197 Prefilled Syringes Market for Orthopedic disorders: Share of Latin America, 2022-2035 (USD Million)
Figure 18.198 Prefilled Syringes Market for Orthopedic disorders: Share of Middle East and Africa, 2022-2035 (Million Units)
Figure 18.199 Prefilled Syringes Market for Orthopedic disorders: Share of Middle East and Africa, 2022-2035 (USD Million)
Figure 18.200 Prefilled Syringes Market for Other disorders: Share of Glass Barrel Syringes, 2022-2035 (USD Million)
Figure 18.201 Prefilled Syringes Market for Other disorders: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (USD Million)
Figure 18.202 Prefilled Syringes Market for Other disorders: Share of Single Chamber Syringes, 2022-2035 (USD Million)
Figure 18.203 Prefilled Syringes Market for Other disorders: Share of Dual Chamber Syringes, 2022-2035 (USD Million)
Figure 18.204 Prefilled Syringes Market for Other disorders: Share of Antibodies, 2022-2035 (USD Million)
Figure 18.205 Prefilled Syringes Market for Other disorders: Share of Peptides, 2022-2035 (USD Million)
Figure 18.206 Prefilled Syringes Market for Other disorders: Share of Small Molecule, 2022-2035 (USD Million)
Figure 18.207 Prefilled Syringes Market for Other disorders: Share of Cell Therapy, 2022-2035 (USD Million)
Figure 18.208 Prefilled Syringes Market for Other disorders: Share of North America, 2022-2035 (Million Units)
Figure 18.209 Prefilled Syringes Market for Other disorders: Share of North America, 2022-2035 (USD Million)
Figure 18.210 Prefilled Syringes Market for Other disorders: Share of Europe, 2022-2035 (Million Units)
Figure 18.211 Prefilled Syringes Market for Other disorders: Share of Europe, 2022-2035 (USD Million)
Figure 18.212 Prefilled Syringes Market for Other disorders: Share of Asia Pacific, 2022-2035 (Million Units)
Figure 18.213 Prefilled Syringes Market for Other disorders: Share of Asia Pacific, 2022-2035 (USD Million)
Figure 18.214 Prefilled Syringes Market for Other disorders: Share of Latin America, 2022-2035 (Million Units)
Figure 18.215 Prefilled Syringes Market for Other disorders: Share of Latin America, 2022-2035 (USD Million)
Figure 18.216 Prefilled Syringes Market for Other disorders: Share of Middle East and Africa, 2022-2035 (Million Units)
Figure 18.217 Prefilled Syringes Market for Other disorders: Share of Middle East and Africa, 2022-2035 (USD Million)
Figure 19.1 Diabetes: Country Wise Distribution of Prevalence and Mortality, 2017
Figure 19.2 FDA Approved Biologics, 2009-2021
Figure 19.3 Top Selling Biologics: Estimated Patent Expiry
Figure 20.1 SWOT Analysis: Overview
Figure 20.2 Prefilled Syringe Recalls: Distribution by Type of Error, 2003-2021
Figure 20.3 Comparison of SWOT Factors: Harvey Ball Analysis
Figure 22.1 Prefilled Syringes: Fill / Finish Process
Figure 22.2 Prefilled Syringes Fill / Finish Service Providers: Distribution by Year of Establishment
Figure 22.3 Prefilled Syringe Fill / Finish Service Providers: Distribution by Geographical Location of Headquarters and Type of Drug Molecule
Figure 22.4 Prefilled Syringe Fill / Finish Service Providers: Distribution by Scale of Operation
Figure 24.1 Concluding Remarks: Prefilled Syringe Market Landscape
Figure 24.2 Concluding Remarks: Big Pharma Initiative
Figure 24.3 Concluding Remarks: Recent Developments
Figure 24.4 Concluding Remarks: Patent Analysis
Figure 24.5 Concluding Remarks: Combination Products
Figure 24.6 Concluding Remarks: KOL Analysis
Figure 24.7 Concluding Remarks: Market Forecast (1/2)
Figure 24.8 Concluding Remarks: Market Forecast (2/2)

List Of Tables

Table 3.1 Drugs: Shifted from Vials to Prefilled Syringe Systems
Table 3.2 Components of Prefilled Syringes
Table 3.3 Classification of Prefilled Syringes
Table 3.4 Advantages of Glass Barrel Fabrication Material
Table 3.5 Glass Barrel Prefilled Syringe Recalls
Table 3.6 Advantages of Plastic Polymer Barrel Fabrication Material
Table 3.7 Pharmaceutical Filling Lines: Steps Performed by Type of Packaging of Prefilled Syringe
Table 4.1 Prefilled Syringes: List of Available / Under Development Devices 
Table 4.2 Prefilled Syringes: List of Developers
Table 6.1 Key Manufacturers of Prefilled Syringes
Table 6.2 Becton Dickinson: Future Outlook
Table 6.3 West Pharmaceutical: Features of Daikyo Crystal Zenith Prefilled Syringe
Table 6.4 West Pharmaceutical: Future Outlook
Table 6.5 Gerresheimer: Features of Gx Glass Prefilled Syringe 
Table 6.6 Gerresheimer: Features of ClearJect Prefilled Syringe 
Table 6.7 Gerresheimer: Features of Gx RTF ClearJect Prefilled Syringe 
Table 6.8 Gerresheimer: Future Outlook
Table 6.9 Ompi: Features of EZ-Fill Fina Prefilled Syringe 
Table 6.10 Ompi: Features of EZ-Fill Nexa Prefilled Syringe
Table 6.11 Ompi: Features of EZ-Fill Alba Prefilled Syringe
Table 6.12 Ompi: Future Outlook
Table 6.13 Schott: Features of syriQ Prefilled Syringe 
Table 6.14 Schott: Features of TopPac Prefilled Syringe
Table 6.15 Schott: Future Outlook
Table 6.16 Nipro: Features of Prefilled Syringe 
Table 6.17 Taisei Kako: Features of VF-Syringes
Table 6.18 Taisei Kako: Features of SIN-Syringes
Table 6.19 Taisei Kako: Features of ClearJect Prefilled Syringes 
Table 6.20 Taisei Kako: Features of FULJECT Passive Type Syringes
Table 6.21 Shandong Zibo: Features of Prefilled Syringes
Table 6.22 Terumo: Features of Plajex Syringes
Table 6.23 Vetter Pharma: Features of Lyo-Ject Glass Prefilled Syringe
Table 6.24 ShandongWeigao: Features of WeGo Glass Prefilled Syringe 
Table 7.1 Add-On Safety Device Manufacturers
Table 7.2 Integrated Prefilled Safety Device Manufacturers 
Table 8.1 FDA Center for Drug and Device Approval
Table 8.2 US: Regulatory Review Timelines
Table 8.3 Regulatory Bodies in EU5 Countries
Table 8.4 Data Requirements and Characteristics of Province-wide HTA Processes in Canada
Table 8.5 Device Classification: Brazil
Table 8.6 Reimbursement and Pricing Approval Process of Prefilled syringes in Australia
Table 8.7 Device Classification: Japan
Table 8.8 Medical Device Reimbursement Categories
Table 8.9 Device Classification: India
Table 8.10 Device Classification: South Korea
Table 8.11 Saudi Arabia: Regulatory Review Timelines
Table 9.1 Prefilled Syringe Combination Products: List of Approved Drugs, 2013-2021
Table 9.2 Prefilled Syringe Combination Products: Information on Approval Year and Key Geographies, 2013-2021
Table 9.3 Prefilled Syringe Combination Products: Information on Dosage Strength
Table 9.4 Prefilled Syringe Combination Products: List of Other Drug Delivery Solutions, 2013-2021
Table 9.5 Prefilled Syringe Combination Products: List of Clinical Stage Drugs, 2013-2021
Table 9.6 Prefilled Syringe Combination Products: List of Developers
Table 9.7 Other Drugs Sold in Prefilled Syringes Format
Table 10.1 Autoimmune Disorders: Leading Approved Drugs, 
Table 10.2 Autoimmune Disorders: Approved Drugs Available in Prefilled Syringes
Table 10.3 Autoimmune Disorders: Prefilled Syringe Approved Drugs Patent Expiry and Biosimilar Development
Table 10.4 Infectious Diseases: Leading Antiviral Drugs
Table 10.5 Infectious Diseases: Antiviral Drugs Available in Prefilled Syringes
Table 10.6 Infectious Diseases: Prefilled Syringe Approved Drugs Patent Expiry and Biosimilar Development
Table 10.7 Infectious Diseases: Leading Vaccines
Table 10.8 Infectious Diseases: Vaccines Available in Prefilled Syringes
Table 10.9 Neurological Disorders: Leading Drugs
Table 10.10 Neurological Disorders: Approved Drugs Available in Prefilled Syringes
Table 10.11 Neurological Disorders: Prefilled Syringe Approved Drugs Patent Expiry and Biosimilar Development
Table 10.12 Metabolic Disorders: Leading Diabetes Drugs
Table 10.13 Metabolic Disorders: Approved Drugs Available in Prefilled Insulin Pen
Table 10.14 Metabolic Disorders: Prefilled Syringe Approved Drugs Patent Expiry and Biosimilar Development
Table 11.1 Marketed Drug Candidates: Most Likely Candidates for Delivery via Prefilled Syringes
Table 11.2 Marketed Drug Candidates: Likely Candidates for Delivery via Prefilled Syringes
Table 11.3 Marketed Drug Candidates: Less Likely Candidates for Delivery via Prefilled Syringes
Table 11.4 Marketed Drug Candidates: Least Likely Candidates for Delivery via Prefilled Syringes
Table 11.5 Clinical Stage Drug Candidates: Most Likely Candidates for Delivery via Prefilled Syringes
Table 11.6 Clinical Stage Drug Candidates: Likely Candidates for Delivery via Prefilled Syringes
Table 11.7 Clinical Stage Drug Candidates: Less Likely Candidates for Delivery via Prefilled Syringes
Table 11.8 Clinical Stage Drug Candidates: Least Likely Candidates for Delivery via Prefilled Syringes
Table 11.9 Opportunities in North America: Most Likely Partners for Prefilled Syringe Combination Products
Table 11.10 Opportunities in North America: Likely Partners for Prefilled Syringe Combination Products
Table 11.11 Opportunities in North America: Less Likely Partners for Prefilled Syringe Combination Products
Table 11.12 Opportunities in North America: Least Likely Partners for Prefilled Syringe Combination Products
Table 11.13 Opportunities in Europe: Most Likely Partners for Prefilled Syringe Combination Products
Table 11.14 Opportunities in Europe: Less Likely Partners for Prefilled Syringe Combination Products
Table 11.15 Opportunities in Europe: Least Likely Partners for Prefilled Syringe Combination Products
Table 11.16 Opportunities in Asia-Pacific and Rest of the World: Most Likely Partners for Prefilled Syringe Combination Products
Table 11.17 Opportunities in Asia-Pacific and Rest of the World: Likely Partners for Prefilled Syringe Combination Products
Table 11.18 Opportunities in Asia-Pacific and Rest of the World: Less Likely Partners for Prefilled Syringe Combination Product Development
Table 13.1 Prefilled Syringes: List of Recent Initiatives, 2019 – 2021
Table 14.1 Patent Analysis: List of Top CPC Symbols
Table 14.2 Patent Analysis: Summary of Benchmarking Analysis
Table 14.3 Patent Analysis: Various Categorizations based on Weighted Valuation Scores
Table 14.4 Patent Portfolio: List of Leading Patents (In Terms of Highest Relative Valuation)
Table 15.1 Prefilled Syringes: List of Key Investigators
Table 16.1 Prefilled Flush Syringes Available in the Market
Table 16.2 Drugs Available with Prefilled Diluent Syringe System
Table 16.3 Contrast Agents Available in Prefilled Syringes
Table 17.1 List of Dual / Multi-Chamber Prefilled Syringes
Table 19.1 Fraction of Global Population above 60 years (in Millions), 2022, 2030 and 2050
Table 19.2 Autoinjector Approvals, 2016-2019
Table 19.3 Marketed Autoinjectors / Pen Injectors Available in Prefilled Syringe
Table 20.1 List of Marketed/Pipeline Needleless Injection Devices
Table 20.2 List of Prefilled Syringe Recalls, 2003-2021
Table 21.1 Prefilled Syringe Component Manufacturers: List of Elastomeric Component Providers
Table 21.2 Prefilled Syringes Elastomeric Container Closure Providers: List of Companies Profiled
Table 21.3 West Pharmaceutical: Company Overview
Table 21.4 West Pharmaceutical: Product Portfolio
Table 21.5 Datwyler Sealing Solutions (a Part of Datwyler Group): Company Overview
Table 21.6 Datwyler Sealing Solutions (a Part of Datwyler Group): Product Details
Table 21.7 Datwyler Sealing Solutions (a Part of Datwyler Group): Recent Developments and Future Outlook
Table 21.8 AptarGroup: Company Overview
Table 21.9 AptarGroup: Product Details
Table 21.10 AptarGroup: Future Outlook
Table 21.11 Becton Dickinson: Company Overview
Table 21.12 Becton Dickinson: Product Details
Table 21.13 Ompi: Company Overview
Table 21.14 Ompi: Product Portfolio
Table 21.15 Lonstroff: Company Overview
Table 21.16 Sumitomo Rubber Industries: Company Overview
Table 21.17 Lonstroff: Product Details
Table 22.1 List of Fill / Finish Service Providers
Table 23.1 List of Autoinjector Devices (Using Prefilled Syringes)
Table 23.2 YpsoMate Autoinjectors: Dimensions of Prefilled Syringes
Table 25.1 Oval Medical Technologies: Key Highlights 
Table 25.2 Intas Pharmaceuticals: Key Highlights 
Table 25.3 IDT Biologika: Key Highlights 
Table 25.4 West Pharmaceutical: Key Highlights 
Table 25.5 Lonstroff: Key Highlights
Table 25.6 IDEO: Key Highlights
Table 26.1 Prefilled Syringes: Distribution by Type of Barrel Fabrication Material
Table 26.2 Prefilled Syringes: Distribution by Number of Barrel Chamber
Table 26.3 Prefilled Syringes: Distribution by Type of Needle System
Table 26.4 Prefilled Syringes: Distribution by Packing Volume of Syringe
Table 26.5 Prefilled Syringes: Distribution by Year of Establishment
Table 26.6 Prefilled Syringes: Distribution by Company Size
Table 26.7 Prefilled Syringes: Distribution by Location of Headquarters
Table 26.8 Prefilled Syringes: Distribution by Company Size and Location of Headquarters
Table 26.9 Prefilled Syringes: Distribution by Geographical Location of Manufacturing Facilities
Table 26.10 Most Active Players: Analysis by Number of Products
Table 26.11 BD Medical: Global Annual Revenue, 2013 – 2021 (USD Billion)
Table 26.12 BD Medical Segments: Distribution of Revenues by Business Segment (2021)
Table 26.13 Pfizer Hospital: Annual Revenues, 2017 – 2021 (USD Million)
Table 26.14 West Pharmaceutical: Annual Revenues, 2013 – 2021 (USD Million)
Table 26.15 West Pharmaceutical: Distribution of Revenues by Business Segment, 2021
Table 26.16 West Pharmaceutical: Distribution of Revenue by Region, 2021
Table 26.17 Gerresheimer: Annual Revenue, 2013 – 6M 2022 (EUR Million)
Table 26.18 Gerresheimer: Distribution of Revenues by Business Divisions, 2021
Table 26.19 Gerresheimer: Distribution of Revenue by Region, 2021
Table 26.20 Stevanato Group: Annual Revenues, 2018 – 6M 2022 (EUR Million)
Table 26.21 Stevanato Group: Distribution of Revenue by Business Segment (2021)
Table 26.22 Stevanato Group: Distribution of Revenue by Region (2021)
Table 26.23 Schott: Annual Revenues, 2013 – 2021 (EUR Million)
Table 26.24 Schott: Distribution of Revenues by Region, (2021)
Table 26.25 Nipro: Annual Revenue, 2013 – 2022 (JPY Billion)
Table 26.26 Nipro: Distribution of Revenues by Business Segment, (2021)
Table 26.27 Nipro: Distribution of Revenue by Region, (2021)
Table 26.28 Terumo: Annual Revenues, 2013 – 3M 2022 (JPY Billion)
Table 26.29 Terumo: Distribution of Revenues by Business Divisions, (2021)
Table 26.30 Wego Prefills Pharmaceutical Packaging: Annual Revenue, 2013 –2021 (JPY Billion)
Table 26.31 Wego Prefills Pharmaceutical Packaging: Distribution of Revenue by Business Divisions, (2021)
Table 26.32 Wego Prefills Pharmaceutical Packaging: Distribution of Revenue by Region, (2021)
Table 26.33 Approved Prefilled Syringe Combination Products: Distribution by Type of Drug Molecule
Table 26.34 Approved Prefilled Syringe Combination Products: Distribution by Approval Year
Table 26.35 Approved Prefilled Syringe Combination Products: Distribution by Geography
Table 26.36 Approved Prefilled Syringe Combination Products: Distribution by Route of Administration
Table 26.37 Approved Prefilled Syringe Combination Products: Distribution by Target Therapeutic Area
Table 26.38 Approved Prefilled Syringe Combination Products: Distribution by Dosage Forms
Table 26.39 Clinical Stage Prefilled Syringe Combination Products: Distribution by Type of Drug Molecule
Table 26.40 Clinical Stage Prefilled Syringe Combination Products: Distribution by Phase of Development
Table 26.41 Clinical Stage Prefilled Syringe Combination Products: Distribution by Phase of Development
Table 26.42 Clinical Stage Prefilled Syringe Combination Products: Distribution by Target Therapeutic Area
Table 26.43 Prefilled Syringe Combination Products Developers: Distribution by Year of Establishment
Table 26.44 Prefilled Syringe Combination Products Developers: Distribution by Company Size
Table 26.45 Prefilled Syringe Combination Products Developers: Distribution by Location of Headquarters
Table 26.46 Sales of Leading Drugs Available in Prefilled Syringes, 2021 (USD Billion)
Table 26.47 Humira: Annual Sales, 2003-2021 (USD Million)
Table 26.48 Enbrel: Annual Sales, 2002-2021 (USD Million)
Table 26.49 Enbrel: Outside the US Sales, 2010-2021 (USD Million)
Table 26.50 Recent Developments: Distribution by Year of Initiative
Table 26.51 Recent Developments: Distribution by Type of Initiative
Table 26.52 Recent Developments: Distribution by Year and Type of Initiative
Table 26.53 Recent Developments: Distribution by Type of Expansion
Table 26.54 Recent Developments: Distribution by Location of Expansion
Table 26.55 Recent Developments: Distribution by Focus Area of Expansion
Table 26.56 Recent Developments: Distribution by Type of Partnership
Table 26.57 Recent Developments: Distribution by Geography
Table 26.58 Most Active Players: Distribution by Number of Initiatives
Table 26.59 Patent Analysis: Distribution by Type of Patent
Table 26.60 Patent Analysis: Cumulative Distribution by Publication Year, 2015-2022
Table 26.61 Patent Analysis: Distribution by Type of Patent and Publication Year
Table 26.62 Patent Analysis: Distribution by Geography
Table 26.63 Patent Analysis: Year-Wise Distribution of Geography
Table 26.64 Patent Analysis: North America Scenario
Table 26.65 Patent Analysis: Europe Scenario
Table 26.66 Patent Analysis: Asia-Pacific Scenario
Table 26.67 Most Active Players: Distribution by Number of Patents
Table 26.68 Key Inventor Analysis: Distribution by Number of Patents
Table 26.69 Patent Analysis: Distribution by Type of Organization
Table 26.70 Patent Analysis: Distribution by Patent Age
Table 26.71 Cost of Prefilled Syringes: Conservative, Base and Optimistic Scenarios, 2022-2035 (USD)
Table 26.72 Global Prefilled Syringe Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (Million Units)
Table 26.73 Global Prefilled Syringe Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 26.74 Prefilled Syringes Market: Distribution by Therapeutic Area, 2022 and 2035
Table 26.75 Global Annual Demand for Prefilled Syringes: Share of Autoimmune Disorders, Conservative, Base and Optimistic Scenarios, 2022-2035 (Million Units)
Table 26.76 Prefilled Syringe Market: Share of Autoimmune Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (USD Million)
Table 26.77 Global Annual Demand for Prefilled Syringes: Share of Infectious Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (Million Units)
Table 26.78 Prefilled Syringe Market: Share of Infectious Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (USD Million)
Table 26.79 Global Annual Demand for Prefilled Syringes: Share of Neurological Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (Million Units)
Table 26.80 Prefilled Syringe Market: Share of Neurological Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (USD Million)
Table 26.81 Global Annual Demand for Prefilled Syringes: Share of Blood Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (Million Units)
Table 26.82 Prefilled Syringe Market: Share of Blood Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (USD Million)
Table 26.83 Global Annual Demand for Prefilled Syringes: Share of Oncological Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (Million Units)
Table 26.84 Prefilled Syringe Market: Share of Oncological Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (USD Million)
Table 26.85 Global Annual Demand for Prefilled Syringes: Share of Respiratory Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (Million Units)
Table 26.86 Prefilled Syringe Market: Share of Respiratory Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (USD Million)
Table 26.87 Global Annual Demand for Prefilled Syringes: Share of Cardiovascular Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (Million Units)
Table 26.88 Prefilled Syringe Market: Share of Cardiovascular Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (USD Million)
Table 26.89 Global Annual Demand for Prefilled Syringes: Share of Metabolic Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (Million Units)
Table 26.90 Prefilled Syringe Market: Share of Metabolic Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (USD Million)
Table 26.91 Global Annual Demand for Prefilled Syringes: Share of Ophthalmologic Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (Million Units)
Table 26.92 Prefilled Syringe Market: Share of Ophthalmologic Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (USD Million)
Table 26.93 Global Annual Demand for Prefilled Syringes: Share of Orthopedic Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (Million Units)
Table 26.94 Prefilled Syringe Market: Share of Orthopedic Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (USD Million)
Table 26.95 Global Annual Demand for Prefilled Syringes: Share of Other Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (Million Units)
Table 26.96 Prefilled Syringe Market: Share of Other Disorders, Conservative, Base and Optimistic Scenarios 2022-2035 (USD Million)
Table 26.97 Prefilled Syringes Market: Distribution by Type of Syringe Barrel Material, 2022-2035 (USD Million)
Table 26.98 Global Annual Demand for Prefilled Syringes: Share of Glass Barrel Prefilled Syringe, Conservative, Base and Optimistic Scenarios, 2022-2035 (Million Units)
Table 26.99 Prefilled Syringe Market: Share of Glass Barrel Prefilled Syringe, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 26.100 Global Annual Demand for Prefilled Syringes: Share of Plastic Barrel Prefilled Syringe, Conservative, Base and Optimistic Scenarios,2022-2035 (Million Units)
Table 26.101 Prefilled Syringe Market: Share of Plastic Barrel Prefilled Syringe, Conservative, Base and Optimistic Scenarios,2022-2035 (USD Million)
Table 26.102 Global Annual Demand for Prefilled Syringes: Share of Single Chambered Prefilled Syringe, Conservative, Base and Optimistic Scenarios,2022-2035 (Million Units)
Table 26.103 Prefilled Syringe Market: Share of Single Chambered Prefilled Syringe, Conservative, Base and Optimistic Scenarios,2022-2035 (USD Million)
Table 26.104 Global Annual Demand for Prefilled Syringes: Share of Dual Chambered Prefilled Syringe, Conservative, Base and Optimistic Scenarios,2022-2035 (Million Units)
Table 26.105 Prefilled Syringe Market: Share of Dual Chambered Prefilled Syringe, Conservative, Base and Optimistic Scenarios,2022-2035 (USD Million)
Table 26.106 Global Annual Demand for Prefilled Syringes: Share of Antibodies, Conservative, Base and Optimistic Scenarios,2022-2035 (Million Units)
Table 26.107 Prefilled Syringe Market: Share of Antibodies, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 26.108 Global Annual Demand for Prefilled Syringes: Share of Protein, Conservative, Base and Optimistic Scenarios, 2022-2035 (Million Units)
Table 26.109 Prefilled Syringe Market: Share of Protein, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 26.110 Global Annual Demand for Prefilled Syringes: Share of Peptide, Conservative, Base and Optimistic Scenarios, 2022-2035 (Million Units)
Table 26.111 Global Annual Demand for Prefilled Syringes: Share of Peptide, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 26.112 Global Annual Demand for Prefilled Syringes: Share of Small Molecule, Conservative, Base and Optimistic Scenarios, 2022-2035 (Million Units)
Table 26.113 Prefilled Syringe Market: Share of Small Molecule, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 26.114 Global Annual Demand for Prefilled Syringes: Share of Vaccines, Conservative, Base and Optimistic Scenarios, 2022-2035 (Million Units)
Table 26.115 Prefilled Syringe Market: Share of Vaccines, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 26.116 Global Annual Demand for Prefilled Syringes: Share of Cell Therapy, Conservative, Base and Optimistic Scenarios, 2022-2035 (Million Units)
Table 26.117 Prefilled Syringe Market: Share of Cell Therapy, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 26.118 Global Annual Demand for Prefilled Syringes: Share of North America, Base Scenario, 2022-2035 (Million Units)
Table 26.119 Prefilled Syringes Market: Share of North America, Base Scenario, 2022-2035 (USD Million)
Table 26.120 Global Annual Demand for Prefilled Syringes: Share of North America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.121 Prefilled Syringes Market: Share of North America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.122 Global Annual Demand for Prefilled Syringes: Share of North America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.123 Prefilled Syringes Market: Share of North America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.124 Global Annual Demand for Prefilled Syringes: Share of Europe, Base Scenario, 2022-2035 (Million Units)
Table 26.125 Prefilled Syringes Market: Share of Europe, Base Scenario, 2022-2035 (USD Million)
Table 26.126 Global Annual Demand for Prefilled Syringes: Share of Europe, Conservative Scenario, 2022-2035 (Million Units)
Table 26.127 Prefilled Syringes Market: Share of Europe, Conservative Scenario, 2022-2035 (USD Million)
Table 26.128 Global Annual Demand for Prefilled Syringes: Share of Europe, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.129 Prefilled Syringes Market: Share of Europe, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.130 Global Annual Demand for Prefilled Syringes: Share of Asia-Pacific, Base Scenario, 2022-2035 (Million Units)
Table 26.131 Prefilled Syringes Market: Share of Asia-Pacific, Base Scenario, 2022-2035 (USD Million)
Table 26.132 Global Annual Demand for Prefilled Syringes: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (Million Units)
Table 26.133 Prefilled Syringes Market: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (USD Million)
Table 26.134 Global Annual Demand for Prefilled Syringes: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.135 Prefilled Syringes Market: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.136 Global Annual Demand for Prefilled Syringes: Share of Latin America, Base Scenario, 2022-2035 (Million Units)
Table 26.137 Prefilled Syringes Market: Share of Latin America, Base Scenario, 2022-2035 (USD Million)
Table 26.138 Global Annual Demand for Prefilled Syringes: Share of Latin America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.139 Prefilled Syringes Market: Share of Latin America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.140 Global Annual Demand for Prefilled Syringes: Share of Latin America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.141 Prefilled Syringes Market: Share of Latin America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.142 Global Annual Demand for Prefilled Syringes: Share of Middle East and North Africa, Base Scenario, 2022-2035 (Million Units)
Table 26.143 Prefilled Syringes Market: Share of Middle East and North Africa, Base Scenario, 2022-2035 (USD Million)
Table 26.144 Global Annual Demand for Prefilled Syringes: Share of Middle East and North Africa, Conservative Scenario, 2022-2035 (Million Units)
Table 26.145 Prefilled Syringes Market: Share of Middle East and North Africa, Conservative Scenario, 2022-2035 (USD Million)
Table 26.146 Global Annual Demand for Prefilled Syringes: Share of Middle East and North Africa, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.147 Prefilled Syringes Market: Share of Middle East and North Africa, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.148 Prefilled Syringes Market: Distribution by Type of syringes, 2022-2035 (USD Million)
Table 26.149 Global Annual Demand for Prefilled Syringes: Share of Specialty Syringes, Conservative, Base and Optimistic Scenarios, 2022-2035 (Million Units)
Table 26.150 Prefilled Syringe Market: Share of Specialty Syringes, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 26.151 Global Annual Demand for Prefilled Syringes: Share of Therapeutic Syringes, Conservative, Base and Optimistic Scenarios, 2022-2035 (Million Units)
Table 26.152 Prefilled Syringe Market: Share of Therapeutic Syringes, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 26.153 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Glass Barrel Prefilled Syringes, 2022-2035 (Million Units)
Table 26.154 Prefilled Syringe Market for Autoimmune Disorders: Share of Glass Barrel Prefilled Syringes, 2022-2035 (USD Million)
Table 26.155 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (Million Units)
Table 26.156 Prefilled Syringe Market for Autoimmune Disorders: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (USD Million)
Table 26.157 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Single Chambered Prefilled Syringes, 2022-2035 (Million Units)
Table 26.158 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Single Chambered Prefilled Syringes, 2022-2035 (USD Million)
Table 26.159 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Dual Chambered Prefilled Syringes, 2022-2035 (Million Units)
Table 26.160 Prefilled Syringe Market for Autoimmune Disorders: Share of Dual Chambered Prefilled Syringes, 2022-2035 (USD Million)
Table 26.161 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Antibodies, 2022-2035 (Million Units)
Table 26.162 Prefilled Syringe Market for Autoimmune Disorders: Share of Antibodies, 2022-2035 (USD Million)
Table 26.163 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Proteins, 2022-2035 (Million Units)
Table 26.164 Prefilled Syringe Market for Autoimmune Disorders: Share of Proteins, 2022-2035 (USD Million)
Table 26.165 Global Annual Demand of Prefilled Syringes Autoimmune Disorders: Share of North America, Base Scenario, 2022-2035 (Million Units)
Table 26.166 Prefilled Syringes Market for Autoimmune Disorders: Share of North America, Base Scenario, 2022-2035 (USD Million)
Table 26.167 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of North America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.168 Prefilled Syringes Market for Autoimmune Disorders: Share of North America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.169 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of North America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.170 Prefilled Syringes Market for Autoimmune Disorders: Share of North America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.171 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Europe, Base Scenario, 2022-2035 (Million Units)
Table 26.172 Prefilled Syringes Market for Autoimmune Disorders: Share of Europe, Base Scenario, 2022-2035 (USD Million)
Table 26.173 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Europe, Conservative Scenario, 2022-2035 (Million Units)
Table 26.174 Prefilled Syringes Market for Autoimmune Disorders: Share of Europe, Conservative Scenario, 2022-2035 (USD Million)
Table 26.175 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.176 Prefilled Syringes Market for Autoimmune Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.177 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (Million Units)
Table 26.178 Prefilled Syringes Market for Autoimmune Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (USD Million)
Table 26.179 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (Million Units)
Table 26.180 Prefilled Syringes Market for Autoimmune Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (USD Million)
Table 26.181 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.182 Prefilled Syringes Market for Autoimmune Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.183 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Latin America, Base Scenario, 2022-2035 (Million Units)
Table 26.184 Prefilled Syringes Market for Autoimmune Disorders: Share of Latin America, Base Scenario, 2022-2035 (USD Million)
Table 26.185 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.186 Prefilled Syringes Market for Autoimmune Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.187 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.188 Prefilled Syringes Market for Autoimmune Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.189 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Middle East and North Africa, Base Scenario, 2022-2035 (Million Units)
Table 26.190 Prefilled Syringes Market: Share of Middle East and North Africa, Base Scenario, 2022-2035 (USD Million)
Table 26.191 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Middle East and North Africa, Conservative Scenario, 2022-2035 (Million Units)
Table 26.192 Prefilled Syringes Market: Share of Middle East and North Africa, Conservative Scenario, 2022-2035 (USD Million)
Table 26.193 Global Annual Demand of Prefilled Syringes for Autoimmune Disorders: Share of Middle East and North Africa, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.194 Prefilled Syringes Market: Share of Middle East and North Africa, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.195 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of Glass Barrel Prefilled Syringes, 2022-2035 (Million Units)
Table 26.196 Prefilled Syringe Market for Infectious Diseases: Share of Glass Barrel Prefilled Syringes, 2022-2035 (USD Million)
Table 26.197 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (Million Units)
Table 26.198 Prefilled Syringe Market for Infectious Diseases: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (USD Million)
Table 26.199 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of Single Chambered Prefilled Syringes, 2022-2035 (Million Units)
Table 26.200 Prefilled Syringe Market for Infectious Diseases: Share of Single Chambered Prefilled Syringes, 2022-2035 (USD Million)
Table 26.201 Global Annual Demand of Prefilled Syringes Infectious Diseases: Share of Dual Chambered Prefilled Syringes, 2022-2035 (Million Units)
Table 26.202 Prefilled Syringe Market for Infectious Diseases: Share of Dual Chambered Prefilled Syringes, 2022-2035 (USD Million)
Table 26.203 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of Vaccines, 2022-2035 (Million Units)
Table 26.204 Prefilled Syringe Market for Infectious Diseases: Share of Vaccines, 2022-2035 (USD Million)
Table 26.205 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of North America, Base Scenario, 2022-2035 (Million Units)
Table 26.206 Prefilled Syringes Market for Infectious Diseases: Share of North America, Base Scenario, 2022-2035 (USD Million)
Table 26.207 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of North America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.208 Prefilled Syringes Market for Infectious Diseases: Share of North America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.209 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of North America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.210 Prefilled Syringes Market for Infectious Diseases: Share of North America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.211 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of Europe, Base Scenario, 2022-2035 (Million Units)
Table 26.212 Prefilled Syringes Market for Infectious Diseases: Share of Europe, Base Scenario, 2022-2035 (USD Million)
Table 26.213 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of Europe, Conservative Scenario, 2022-2035 (Million Units)
Table 26.214 Prefilled Syringes Market for Infectious Diseases: Share of Europe, Conservative Scenario, 2022-2035 (USD Million)
Table 26.215 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of Europe, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.216 Prefilled Syringes Market for Infectious Diseases: Share of Europe, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.217 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of Asia-Pacific, Base Scenario, 2022-2035 (Million Units)
Table 26.218 Prefilled Syringes Market for Infectious Diseases: Share of Asia-Pacific, Base Scenario, 2022-2035 (USD Million)
Table 26.219 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (Million Units)
Table 26.220 Prefilled Syringes Market for Infectious Diseases: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (USD Million)
Table 26.221 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.222 Prefilled Syringes Market for Infectious Diseases: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.223 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of Latin America, Base Scenario, 2022-2035 (Million Units)
Table 26.224 Prefilled Syringes Market for Infectious Diseases: Share of Latin America, Base Scenario, 2022-2035 (USD Million)
Table 26.225 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of Latin America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.226 Prefilled Syringes Market for Infectious Diseases: Share of Latin America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.227 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of Latin America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.228 Prefilled Syringes Market for Infectious Diseases: Share of Latin America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.229 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of Middle East and North Africa, Base Scenario, 2022-2035 (Million Units)
Table 26.230 Prefilled Syringes Market for Infectious Diseases: Share of Middle East and North Africa, Base Scenario, 2022-2035 (USD Million)
Table 26.231 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of Middle East and North Africa, Conservative Scenario, 2022-2035 (Million Units)
Table 26.232 Prefilled Syringes Market for Infectious Diseases: Share of Middle East and North Africa, Conservative Scenario, 2022-2035 (USD Million)
Table 26.233 Global Annual Demand of Prefilled Syringes for Infectious Diseases: Share of Middle East and North Africa, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.234 Prefilled Syringes Market for Infectious Diseases: Share of Middle East and North Africa, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.235 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of Glass Barrel Prefilled Syringes, 2022-2035 (Million Units)
Table 26.236 Prefilled Syringe Market for Neurological Disorders: Share of Glass Barrel Prefilled Syringes, 2022-2035 (USD Million)
Table 26.237 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (Million Units)
Table 26.238 Prefilled Syringe Market for Neurological Disorders: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (USD Million)
Table 26.239 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of Single Chambered Prefilled Syringes, 2022-2035 (Million Units)
Table 26.240 Prefilled Syringe Market for Neurological Disorders: Share of Single Chambered Prefilled Syringes, 2022-2035 (USD Million)
Table 26.241 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of Dual Chambered Prefilled Syringes, 2022-2035 (Million Units)
Table 26.242 Prefilled Syringe Market for Neurological Disorders: Share of Dual Chambered Prefilled Syringes, 2022-2035 (USD Million)
Table 26.243 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of Antibodies, 2022-2035 (Million Units)
Table 26.244 Prefilled Syringe Market for Neurological Disorders: Share of Antibodies, 2022-2035 (USD Million)
Table 26.245 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of North America, Base Scenario, 2022-2035 (Million Units)
Table 26.246 Prefilled Syringes Market for Neurological Disorders: Share of North America, Base Scenario, 2022-2035 (USD Million)
Table 26.247 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of North America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.248 Prefilled Syringes Market for Neurological Disorders: Share of North America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.249 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of North America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.250 Prefilled Syringes Market for Neurological Disorders: Share of North America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.251 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of Europe, Base Scenario, 2022-2035 (Million Units)
Table 26.252 Prefilled Syringes Market for Neurological Disorders: Share of Europe, Base Scenario, 2022-2035 (USD Million)
Table 26.253 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of Europe, Conservative Scenario, 2022-2035 (Million Units)
Table 26.254 Prefilled Syringes Market for Neurological Disorders: Share of Europe, Conservative Scenario, 2022-2035 (USD Million)
Table 26.255 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.256 Prefilled Syringes Market for Neurological Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.257 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (Million Units)
Table 26.258 Prefilled Syringes Market for Neurological Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (USD Million)
Table 26.259 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (Million Units)
Table 26.260 Prefilled Syringes Market for Neurological Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (USD Million)
Table 26.261 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.262 Prefilled Syringes Market for Neurological Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.263 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of Latin America, Base Scenario, 2022-2035 (Million Units)
Table 26.264 Prefilled Syringes Market for Neurological Disorders: Share of Latin America, Base Scenario, 2022-2035 (USD Million)
Table 26.265 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.266 Prefilled Syringes Market for Neurological Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.267 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.268 Prefilled Syringes Market for Neurological Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.269 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of Middle East and North Africa, Base Scenario, 2022-2035 (Million Units)
Table 26.270 Prefilled Syringes Market for Neurological Disorders Share of Middle East and North Africa, Base Scenario, 2022-2035 (USD Million)
Table 26.271 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of Middle East and North Africa, Conservative Scenario, 2022-2035 (Million Units)
Table 26.272 Prefilled Syringes Market for Neurological Disorders: Share of Middle East and North Africa, Conservative Scenario, 2022-2035 (USD Million)
Table 26.273 Global Annual Demand of Prefilled Syringes for Neurological Disorders: Share of Middle East and North Africa, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.274 Prefilled Syringes Market for Neurological Disorders: Share of Middle East and North Africa, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.275 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of Glass Barrel Prefilled Syringes, 2022-2035 (Million Units)
Table 26.276 Prefilled Syringe Market for Blood Disorders: Share of Glass Barrel Prefilled Syringes, 2022-2035 (USD Million)
Table 26.277 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (Million Units)
Table 26.278 Prefilled Syringe Market for Blood Disorders: Share of Plastic Barrel Prefilled Syringes, 2022-2035 (USD Million)
Table 26.279 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of Single Chambered Prefilled Syringes, 2022-2035 (Million Units)
Table 26.280 Prefilled Syringe Market for Blood Disorders: Share of Single Chambered Prefilled Syringes, 2022-2035 (USD Million)
Table 26.281 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of Dual Chambered Prefilled Syringes, 2022-2035 (Million Units)
Table 26.282 Prefilled Syringe Market for Blood Disorders: Share of Dual Chambered Prefilled Syringes, 2022-2035 (USD Million)
Table 26.283 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of Proteins, 2022-2035 (Million Units)
Table 26.284 Prefilled Syringe Market for Blood Disorders: Share of Proteins, 2022-2035 (USD Million)
Table 26.285 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of North America, Base Scenario, 2022-2035 (Million Units)
Table 26.286 Prefilled Syringes Market for Blood Disorders: Share of North America, Base Scenario, 2022-2035 (USD Million)
Table 26.287 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of North America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.288 Prefilled Syringes Market for Blood Disorders: Share of North America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.289 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of North America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.290 Prefilled Syringes Market for Blood Disorders: Share of North America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.291 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of Europe, Base Scenario, 2022-2035 (Million Units)
Table 26.292 Prefilled Syringes Market for Blood Disorders: Share of Europe, Base Scenario, 2022-2035 (USD Million)
Table 26.293 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of Europe, Conservative Scenario, 2022-2035 (Million Units)
Table 26.294 Prefilled Syringes Market for Blood Disorders: Share of Europe, Conservative Scenario, 2022-2035 (USD Million)
Table 26.295 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.296 Prefilled Syringes Market for Blood Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.297 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (Million Units)
Table 26.298 Prefilled Syringes Market for Blood Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (USD Million)
Table 26.299 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (Million Units)
Table 26.300 Prefilled Syringes Market for Blood Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (USD Million)
Table 26.301 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.302 Prefilled Syringes Market for Blood Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.303 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of Latin America, Base Scenario, 2022-2035 (Million Units)
Table 26.304 Prefilled Syringes Market for Blood Disorders: Share of Latin America, Base Scenario, 2022-2035 (USD Million)
Table 26.305 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.306 Prefilled Syringes Market for Blood Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.307 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.308 Prefilled Syringes Market for Blood Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.309 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of Middle East and Africa, Base Scenario, 2022-2035 (Million Units)
Table 26.310 Prefilled Syringes Market for Blood Disorders Share of Middle East and Africa, Base Scenario, 2022-2035 (USD Million)
Table 26.311 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of Middle East and Africa, Conservative Scenario, 2022-2035 (Million Units)
Table 26.312 Prefilled Syringes Market for Blood Disorders: Share of Middle East and Africa, Conservative Scenario, 2022-2035 (USD Million)
Table 26.313 Global Annual Demand of Prefilled Syringes for Blood Disorders: Share of Middle East and Africa, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.314 Prefilled Syringes Market for Blood Disorders: Share of Middle East and Africa, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.315 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Glass Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.316 Prefilled Syringe Market for Oncological Disorders: Share of Glass Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.317 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Plastic Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.318 Prefilled Syringe Market for Oncological Disorders: Share of Plastic Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.319 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Single Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.320 Prefilled Syringe Market for Oncological Disorders: Share of Single Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.321 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Dual Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.322 Prefilled Syringe Market for Oncological Disorders: Share of Dual Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.323 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Antibodies, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.324 Prefilled Syringe Market for Oncological Disorders: Share of Antibodies, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.325 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Proteins, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.326 Prefilled Syringe Market for Oncological Disorders: Share of Proteins, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.327 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of North America, Base Scenario, 2022-2035 (Million Units)
Table 26.328 Prefilled Syringes Market for Oncological Disorders: Share of North America, Base Scenario, 2022-2035 (USD Million)
Table 26.329 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of North America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.330 Prefilled Syringes Market for Oncological Disorders: Share of North America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.331 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of North America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.332 Prefilled Syringes Market for Oncological Disorders: Share of North America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.333 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Europe, Base Scenario, 2022-2035 (Million Units)
Table 26.334 Prefilled Syringes Market for Oncological Disorders: Share of Europe, Base Scenario, 2022-2035 (USD Million)
Table 26.335 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Europe, Conservative Scenario, 2022-2035 (Million Units)
Table 26.336 Prefilled Syringes Market for Oncological Disorders: Share of Europe, Conservative Scenario, 2022-2035 (USD Million)
Table 26.337 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.338 Prefilled Syringes Market for Oncological Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.339 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (Million Units)
Table 26.340 Prefilled Syringes Market for Oncological Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (USD Million)
Table 26.341 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (Million Units)
Table 26.342 Prefilled Syringes Market for Oncological Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (USD Million)
Table 26.343 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.344 Prefilled Syringes Market for Oncological Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.345 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Latin America, Base Scenario, 2022-2035 (Million Units)
Table 26.346 Prefilled Syringes Market for Oncological Disorders: Share of Latin America, Base Scenario, 2022-2035 (USD Million)
Table 26.347 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.348 Prefilled Syringes Market for Oncological Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.349 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.350 Prefilled Syringes Market for Oncological Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.351 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Middle East and Africa, Base Scenario, 2022-2035 (Million Units)
Table 26.352 Prefilled Syringes Market for Oncological Disorders Share of Middle East and Africa, Base Scenario, 2022-2035 (USD Million)
Table 26.353 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Middle East and Africa, Conservative Scenario, 2022-2035 (Million Units)
Table 26.354 Prefilled Syringes Market for Oncological Disorders: Share of Middle East and Africa, Conservative Scenario, 2022-2035 (USD Million)
Table 26.355 Global Annual Demand of Prefilled Syringes for Oncological Disorders: Share of Middle East and Africa, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.356 Prefilled Syringes Market for Oncological Disorders: Share of Middle East and Africa, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.357 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of Glass Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.358 Prefilled Syringe Market for Metabolic Disorders: Share of Glass Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.359 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of Plastic Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.360 Prefilled Syringe Market for Metabolic Disorders: Share of Plastic Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.361 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of Single Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.362 Prefilled Syringe Market for Metabolic Disorders: Share of Single Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.363 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of Dual Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.364 Prefilled Syringe Market for Metabolic Disorders: Share of Dual Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.365 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of Peptides, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.366 Prefilled Syringe Market for Metabolic Disorders: Share of Peptides, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.367 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of North America, Base Scenario, 2022-2035 (Million Units)
Table 26.368 Prefilled Syringes Market for Metabolic Disorders: Share of North America, Base Scenario, 2022-2035 (USD Million)
Table 26.369 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of North America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.370 Prefilled Syringes Market for Metabolic Disorders: Share of North America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.371 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of North America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.372 Prefilled Syringes Market for Metabolic Disorders: Share of North America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.373 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of Europe, Base Scenario, 2022-2035 (Million Units)
Table 26.374 Prefilled Syringes Market for Metabolic Disorders: Share of Europe, Base Scenario, 2022-2035 (USD Million)
Table 26.375 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of Europe, Conservative Scenario, 2022-2035 (Million Units)
Table 26.376 Prefilled Syringes Market for Metabolic Disorders: Share of Europe, Conservative Scenario, 2022-2035 (USD Million)
Table 26.377 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.378 Prefilled Syringes Market for Metabolic Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.379 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (Million Units)
Table 26.380 Prefilled Syringes Market for Metabolic Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (USD Million)
Table 26.381 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (Million Units)
Table 26.382 Prefilled Syringes Market for Metabolic Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (USD Million)
Table 26.383 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.384 Prefilled Syringes Market for Metabolic Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.385 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of Latin America, Base Scenario, 2022-2035 (Million Units)
Table 26.386 Prefilled Syringes Market for Metabolic Disorders: Share of Latin America, Base Scenario, 2022-2035 (USD Million)
Table 26.387 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.388 Prefilled Syringes Market for Metabolic Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.389 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.390 Prefilled Syringes Market for Metabolic Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.391 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of Middle East and Africa, Base Scenario, 2022-2035 (Million Units)
Table 26.392 Prefilled Syringes Market for Metabolic Disorders Share of Middle East and Africa, Base Scenario, 2022-2035 (USD Million)
Table 26.393 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of Middle East and Africa, Conservative Scenario, 2022-2035 (Million Units)
Table 26.394 Prefilled Syringes Market for Metabolic Disorders: Share of Middle East and Africa, Conservative Scenario, 2022-2035 (USD Million)
Table 26.395 Global Annual Demand of Prefilled Syringes for Metabolic Disorders: Share of Middle East and Africa, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.396 Prefilled Syringes Market for Metabolic Disorders: Share of Middle East and Africa, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.397 Global Annual Demand of Prefilled Syringes Respiratory Disorders: Share of Glass Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.398 Prefilled Syringe Market for Respiratory Disorders: Share of Glass Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.399 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of Plastic Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.400 Prefilled Syringe Market for Respiratory Disorders: Share of Plastic Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.401 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of Single Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.402 Prefilled Syringe Market for Respiratory Disorders: Share of Single Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.403 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of Dual Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.404 Prefilled Syringe Market for Respiratory Disorders: Share of Dual Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.405 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of Antibodies, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.406 Prefilled Syringe Market for Respiratory Disorders: Share of Antibodies, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.407 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of North America, Base Scenario, 2022-2035 (Million Units)
Table 26.408 Prefilled Syringes Market for Respiratory Disorders: Share of North America, Base Scenario, 2022-2035 (USD Million)
Table 26.409 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of North America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.410 Prefilled Syringes Market for Respiratory Disorders: Share of North America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.411 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of North America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.412 Prefilled Syringes Market for Respiratory Disorders: Share of North America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.413 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of Europe, Base Scenario, 2022-2035 (Million Units)
Table 26.414 Prefilled Syringes Market for Respiratory Disorders: Share of Europe, Base Scenario, 2022-2035 (USD Million)
Table 26.415 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of Europe, Conservative Scenario, 2022-2035 (Million Units)
Table 26.416 Prefilled Syringes Market for Respiratory Disorders: Share of Europe, Conservative Scenario, 2022-2035 (USD Million)
Table 26.417 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.418 Prefilled Syringes Market for Respiratory Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.419 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (Million Units)
Table 26.420 Prefilled Syringes Market for Respiratory Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (USD Million)
Table 26.421 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (Million Units)
Table 26.422 Prefilled Syringes Market for Respiratory Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (USD Million)
Table 26.423 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.424 Prefilled Syringes Market for Respiratory Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.425 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of Latin America, Base Scenario, 2022-2035 (Million Units)
Table 26.426 Prefilled Syringes Market for Respiratory Disorders: Share of Latin America, Base Scenario, 2022-2035 (USD Million)
Table 26.427 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.428 Prefilled Syringes Market for Respiratory Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.429 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.430 Prefilled Syringes Market for Respiratory Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.431 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of Middle East and Africa, Base Scenario, 2022-2035 (Million Units)
Table 26.432 Prefilled Syringes Market for Respiratory Disorders Share of Middle East and Africa, Base Scenario, 2022-2035 (USD Million)
Table 26.433 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of Middle East and Africa, Conservative Scenario, 2022-2035 (Million Units)
Table 26.434 Prefilled Syringes Market for Respiratory Disorders: Share of Middle East and Africa, Conservative Scenario, 2022-2035 (USD Million)
Table 26.435 Global Annual Demand of Prefilled Syringes for Respiratory Disorders: Share of Middle East and Africa, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.436 Prefilled Syringes Market for Respiratory Disorders: Share of Middle East and Africa, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.437 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of Glass Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.438 Prefilled Syringe Market for Cardiovascular Disorders: Share of Glass Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.439 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of Plastic Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.440 Prefilled Syringe Market for Cardiovascular Disorders: Share of Plastic Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.441 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of Single Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.442 Prefilled Syringe Market for Cardiovascular Disorders: Share of Single Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.443 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of Dual Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.444 Prefilled Syringe Market for Cardiovascular Disorders: Share of Dual Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.445 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of Cell Therapy, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.446 Prefilled Syringe Market for Cardiovascular Disorders: Share of Cell Therapy, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.447 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of North America, Base Scenario, 2022-2035 (Million Units)
Table 26.448 Prefilled Syringes Market for Cardiovascular Disorders: Share of North America, Base Scenario, 2022-2035 (USD Million)
Table 26.449 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of North America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.450 Prefilled Syringes Market for Cardiovascular Disorders: Share of North America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.451 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of North America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.452 Prefilled Syringes Market for Cardiovascular Disorders: Share of North America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.453 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of Europe, Base Scenario, 2022-2035 (Million Units)
Table 26.454 Prefilled Syringes Market for Cardiovascular Disorders: Share of Europe, Base Scenario, 2022-2035 (USD Million)
Table 26.455 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of Europe, Conservative Scenario, 2022-2035 (Million Units)
Table 26.456 Prefilled Syringes Market for Cardiovascular Disorders: Share of Europe, Conservative Scenario, 2022-2035 (USD Million)
Table 26.457 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.458 Prefilled Syringes Market for Cardiovascular Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.459 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (Million Units)
Table 26.460 Prefilled Syringes Market for Cardiovascular Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (USD Million)
Table 26.461 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (Million Units)
Table 26.462 Prefilled Syringes Market for Cardiovascular Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (USD Million)
Table 26.463 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.464 Prefilled Syringes Market for Cardiovascular Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.465 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of Latin America, Base Scenario, 2022-2035 (Million Units)
Table 26.466 Prefilled Syringes Market for Cardiovascular Disorders: Share of Latin America, Base Scenario, 2022-2035 (USD Million)
Table 26.467 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.468 Prefilled Syringes Market for Cardiovascular Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.469 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.470 Prefilled Syringes Market for Cardiovascular Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.471 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of Middle East and Africa, Base Scenario, 2022-2035 (Million Units)
Table 26.472 Prefilled Syringes Market for Cardiovascular Disorders Share of Middle East and Africa, Base Scenario, 2022-2035 (USD Million)
Table 26.473 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of Middle East and Africa, Conservative Scenario, 2022-2035 (Million Units)
Table 26.474 Prefilled Syringes Market for Cardiovascular Disorders: Share of Middle East and Africa, Conservative Scenario, 2022-2035 (USD Million)
Table 26.475 Global Annual Demand of Prefilled Syringes for Cardiovascular Disorders: Share of Middle East and Africa, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.476 Prefilled Syringes Market for Cardiovascular Disorders: Share of Middle East and Africa, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.477 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Glass Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.478 Prefilled Syringe Market for Ophthalmic Disorders: Share of Glass Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.479 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Plastic Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.480 Prefilled Syringe Market for Ophthalmic Disorders: Share of Plastic Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.481 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Single Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.482 Prefilled Syringe Market for Ophthalmic Disorders: Share of Single Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.483 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Dual Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.484 Prefilled Syringe Market for Ophthalmic Disorders: Share of Dual Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.485 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Antibodies, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.486 Prefilled Syringe Market for Ophthalmic Disorders: Share of Antibodies, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.487 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Protein, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.488 Prefilled Syringe Market for Ophthalmic Disorders: Share of Protein, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.489 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of North America, Base Scenario, 2022-2035 (Million Units)
Table 26.490 Prefilled Syringes Market for Ophthalmic Disorders: Share of North America, Base Scenario, 2022-2035 (USD Million)
Table 26.491 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of North America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.492 Prefilled Syringes Market for Ophthalmic Disorders: Share of North America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.493 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of North America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.494 Prefilled Syringes Market for Ophthalmic Disorders: Share of North America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.495 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Europe, Base Scenario, 2022-2035 (Million Units)
Table 26.496 Prefilled Syringes Market for Ophthalmic Disorders: Share of Europe, Base Scenario, 2022-2035 (USD Million)
Table 26.497 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Europe, Conservative Scenario, 2022-2035 (Million Units)
Table 26.498 Prefilled Syringes Market for Ophthalmic Disorders: Share of Europe, Conservative Scenario, 2022-2035 (USD Million)
Table 26.499 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.500 Prefilled Syringes Market for Ophthalmic Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.501 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (Million Units)
Table 26.502 Prefilled Syringes Market for Ophthalmic Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (USD Million)
Table 26.503 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (Million Units)
Table 26.504 Prefilled Syringes Market for Ophthalmic Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (USD Million)
Table 26.505 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.506 Prefilled Syringes Market for Ophthalmic Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.507 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Latin America, Base Scenario, 2022-2035 (Million Units)
Table 26.508 Prefilled Syringes Market for Ophthalmic Disorders: Share of Latin America, Base Scenario, 2022-2035 (USD Million)
Table 26.509 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.510 Prefilled Syringes Market for Ophthalmic Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.511 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.512 Prefilled Syringes Market for Ophthalmic Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.513 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Middle East and Africa, Base Scenario, 2022-2035 (Million Units)
Table 26.514 Prefilled Syringes Market for Ophthalmic Disorders Share of Middle East and Africa, Base Scenario, 2022-2035 (USD Million)
Table 26.515 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Middle East and Africa, Conservative Scenario, 2022-2035 (Million Units)
Table 26.516 Prefilled Syringes Market for Ophthalmic Disorders: Share of Middle East and Africa, Conservative Scenario, 2022-2035 (USD Million)
Table 26.517 Global Annual Demand of Prefilled Syringes for Ophthalmic Disorders: Share of Middle East and Africa, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.518 Prefilled Syringes Market for Ophthalmic Disorders: Share of Middle East and Africa, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.519 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Glass Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.520 Prefilled Syringe Market for Orthopedic Disorders: Share of Glass Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.521 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Plastic Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.522 Prefilled Syringe Market for Orthopedic Disorders: Share of Plastic Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.523 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Single Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.524 Prefilled Syringe Market for Orthopedic Disorders: Share of Single Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.525 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Dual Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.526 Prefilled Syringe Market for Orthopedic Disorders: Share of Dual Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.527 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Antibodies, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.528 Prefilled Syringe Market for Orthopedic Disorders: Share of Antibodies, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.529 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Small Molecules, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.530 Prefilled Syringe Market for Orthopedic Disorders: Share of Small Molecules, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.531 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Cell Therapy, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.532 Prefilled Syringe Market for Orthopedic Disorders: Share of Cell Therapy, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.533 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of North America, Base Scenario, 2022-2035 (Million Units)
Table 26.534 Prefilled Syringes Market for Orthopedic Disorders: Share of North America, Base Scenario, 2022-2035 (USD Million)
Table 26.535 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of North America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.536 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of North America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.537 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of North America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.538 Prefilled Syringes Market for Orthopedic Disorders: Share of North America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.539 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Europe, Base Scenario, 2022-2035 (Million Units)
Table 26.540 Prefilled Syringes Market for Orthopedic Disorders: Share of Europe, Base Scenario, 2022-2035 (USD Million)
Table 26.541 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Europe, Conservative Scenario, 2022-2035 (Million Units)
Table 26.542 Prefilled Syringes Market for Orthopedic Disorders: Share of Europe, Conservative Scenario, 2022-2035 (USD Million)
Table 26.543 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.544 Prefilled Syringes Market for Orthopedic Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.545 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (Million Units)
Table 26.546 Prefilled Syringes Market for Orthopedic Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (USD Million)
Table 26.547 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (Million Units)
Table 26.548 Prefilled Syringes Market for Orthopedic Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (USD Million)
Table 26.549 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.550 Prefilled Syringes Market for Orthopedic Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.551 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Latin America, Base Scenario, 2022-2035 (Million Units)
Table 26.552 Prefilled Syringes Market for Orthopedic Disorders: Share of Latin America, Base Scenario, 2022-2035 (USD Million)
Table 26.553 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.554 Prefilled Syringes Market for Orthopedic Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.555 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.556 Prefilled Syringes Market for Orthopedic Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.557 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Middle East and Africa, Base Scenario, 2022-2035 (Million Units)
Table 26.558 Prefilled Syringes Market for Orthopedic Disorders Share of Middle East and Africa, Base Scenario, 2022-2035 (USD Million)
Table 26.559 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Middle East and Africa, Conservative Scenario, 2022-2035 (Million Units)
Table 26.560 Prefilled Syringes Market for Orthopedic Disorders: Share of Middle East and Africa, Conservative Scenario, 2022-2035 (USD Million)
Table 26.561 Global Annual Demand of Prefilled Syringes for Orthopedic Disorders: Share of Middle East and Africa, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.562 Prefilled Syringes Market for Orthopedic Disorders: Share of Middle East and Africa, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.563 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Glass Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.564 Prefilled Syringe Market for Other Disorders: Share of Glass Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.565 Global Annual Demand of Prefilled Syringes for for Other Disorders: Share of Plastic Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.566 Prefilled Syringe Market for Other Disorders: Share of Plastic Barrel Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.567 Global Annual Demand of Prefilled Syringes for for Other Disorders: Share of Single Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.568 Prefilled Syringe Market for Other Disorders: Share of Single Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.569 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Dual Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.570 Prefilled Syringe Market for Other Disorders: Share of Dual Chambered Prefilled Syringes, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.571 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Antibodies, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.572 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Antibodies, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.573 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Peptides, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.574 Prefilled Syringe Market for Other Disorders: Share of Peptides, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.575 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Small Molecules, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.576 Prefilled Syringe Market for Other Disorders: Share of Small Molecules, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.577 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Cell Therapy, Conservative, Base and Optimistic Scenario 2022-2035 (Million Units)
Table 26.578 Prefilled Syringe Market for Other Disorders: Share of Cell Therapy, Conservative, Base and Optimistic Scenario 2022-2035 (USD Million)
Table 26.579 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of North America, Base Scenario, 2022-2035 (Million Units)
Table 26.580 Prefilled Syringes Market for Other Disorders: Share of North America, Base Scenario, 2022-2035 (USD Million)
Table 26.581 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of North America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.582 Prefilled Syringes Market for Other Disorders: Share of North America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.583 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of North America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.584 Prefilled Syringes Market for Other Disorders: Share of North America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.585 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Europe, Base Scenario, 2022-2035 (Million Units)
Table 26.586 Prefilled Syringes Market for Other Disorders: Share of Europe, Base Scenario, 2022-2035 (USD Million)
Table 26.587 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Europe, Conservative Scenario, 2022-2035 (Million Units)
Table 26.588 Prefilled Syringes Market for Other Disorders: Share of Europe, Conservative Scenario, 2022-2035 (USD Million)
Table 26.589 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.590 Prefilled Syringes Market for Other Disorders: Share of Europe, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.591 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (Million Units)
Table 26.592 Prefilled Syringes Market for Other Disorders: Share of Asia-Pacific, Base Scenario, 2022-2035 (USD Million)
Table 26.593 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (Million Units)
Table 26.594 Prefilled Syringes Market for Other Disorders: Share of Asia-Pacific, Conservative Scenario, 2022-2035 (USD Million)
Table 26.595 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.596 Prefilled Syringes Market for Other Disorders: Share of Asia-Pacific, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.597 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Latin America, Base Scenario, 2022-2035 (Million Units)
Table 26.598 Prefilled Syringes Market for Other Disorders: Share of Latin America, Base Scenario, 2022-2035 (USD Million)
Table 26.599 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (Million Units)
Table 26.600 Prefilled Syringes Market for Other Disorders: Share of Latin America, Conservative Scenario, 2022-2035 (USD Million)
Table 26.601 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.602 Prefilled Syringes Market for Other Disorders: Share of Latin America, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.603 Global Annual Demand of Prefilled Syringes for Other Disorders:Share of Middle East and Africa, Base Scenario, 2022-2035 (Million Units)
Table 26.604 Prefilled Syringes Market for Other Disorders Share of Middle East and Africa, Base Scenario, 2022-2035 (USD Million)
Table 26.605 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Middle East and Africa, Conservative Scenario, 2022-2035 (Million Units)
Table 26.606 Prefilled Syringes Market for Other Disorders: Share of Middle East and Africa, Conservative Scenario, 2022-2035 (USD Million)
Table 26.607 Global Annual Demand of Prefilled Syringes for Other Disorders: Share of Middle East and Africa, Optimistic Scenario, 2022-2035 (Million Units)
Table 26.608 Prefilled Syringes Market for Other Disorders: Share of Middle East and Africa, Optimistic Scenario, 2022-2035 (USD Million)
Table 26.609 Prefilled Syringe Recalls: Distribution by Type of Error, 2003 - 2021
Table 26.610 FDA Approved Biologics, 2009-2021
Table 26.611 Datwyler Group: Global Annual Revenue, 2013–2021 (CHF Million)
Table 26.612 Aptar Pharma: Global Annual Revenue, 2013–2021 (USD Billion)
Table 26.613 Sumitomo Rubber Industries: Global Annual Revenue, 2013–9M 2019 (JPY Billion)
Table 26.614 Prefilled Syringe Fill / Finish Services Providers: Distribution by Year of Establishment
Table 26.615 Prefilled Syringe Fill / Finish Services Providers: Distribution by Scale of Operation

List Of Companies

The following companies and organizations have been mentioned in the report

  1. 89bio
  2. Abbott Laboratories
  3. AbbVie
  4. Accord Healthcare  
  5. Adamis Pharmaceuticals  
  6. Adimmune  
  7. Advance Pharmalab
  8. Aenova
  9. AEON Biopharma
  10. Ajinomoto Bio-Pharma Services
  11. Akums Drugs & Pharmaceuticals
  12. Alcami
  13. Alder BioPharmaceuticals
  14. Alexion Pharmaceuticals
  15. Alfasigma
  16. Alkermes
  17. Allakos
  18. Allergan
  19. Alvogen
  20. Alvotech
  21. Amgen
  22. Amphastar Pharmaceuticals
  23. Amryt
  24. Andes Biotechnologies
  25. AnGes
  26. Anhui Huafeng Pharmaceutical Rubber
  27. ApcinteX (Acquired by Centessa Pharmaceuticals)
  28. Apotek Produktion & Laboratorier
  29. Apotex
  30. Aptar Pharma
  31. Araclon Biotech
  32. Arecor Therapeutics
  33. argenx
  34. Arrowhead Pharmaceuticals
  35. ARTE
  36. Asarina Pharma
  37. Ascendis Pharma
  38. Ashvattha Therapeutics
  39. Aspen Pharmacare
  40. Aspire Life Sciences
  41. ASST Fatebenefratelli Sacco
  42. Astellas Pharma
  43. Astex Pharmaceuticals
  44. AstraZeneca
  45. Atlant Clinical
  46. Atridia
  47. B. Braun
  48. Baxter BioPharma Solutions
  49. Bayer
  50. Becton Dickinson
  51. Berkshire Sterile Manufacturing
  52. Beximco Pharma
  53. Bharat Biotech
  54. BIOCAD
  55. Biocon
  56. Biogen
  57. Bioinova
  58. Birgi Mefar
  59. Boehringer Ingelheim
  60. Bone Therapeutics
  61. Bristol Myers Squibb
  62. Caliway Biopharmaceuticals
  63. Camurus 
  64. CARBOGEN AMCIS
  65. Cardinal Health
  66. CardioVascular BioTherapeutics
  67. Catalent Biologics
  68. Celgene
  69. Celldex Therapeutics
  70. Celltrion Healthcare
  71. Cenexi
  72. Centrexion Therapeutics
  73. Chong Kun Dang Pharmaceutical
  74. Chugai Pharmaceutical
  75. CinnaGen
  76. Ciron
  77. Clinuvel Pharmaceuticals
  78. Coherus BioSciences
  79. Consort Medical
  80. CordenPharma
  81. Credence MedSystems
  82. CSL Behring
  83. Cumberland Pharmaceuticals
  84. Curia (formerly known as AMRI)
  85. Cutia Therapeutics
  86. Cycle Pharmaceuticals
  87. Daewoong Pharmaceutical    
  88. Daiichi Sankyo
  89. Danyang Jincheng Medical Rubber & Plastics
  90. Data Management 365
  91. Datwyler
  92. Delpharm
  93. Dicerna Pharmaceuticals
  94. Dynavax Technologies
  95. Edge Pharma
  96. Eiger BioPharmaceuticals
  97. Eisai
  98. Eli Lilly and Company
  99. Emcure Pharmaceuticals
  100. EMD Serono
  101. Emergent BioSolutions
  102. Endocard
  103. Ethypharm
  104. Eureka Forbes
  105. Eurofarma
  106. EVER Pharma
  107. Express Service Import Export
  108. Ferring Pharmaceuticals
  109. Foresee Pharmaceuticals
  110. Fresenius Kabi
  111. Fujian Shengdi Pharmaceutical
  112. Fujifilm Toyama Chemical
  113. Galaxy Pharmaceuticals
  114. GC Pharma
  115. GemVax & KAEL
  116. Genentech
  117. Generon
  118. Genmab
  119. Gerresheimer
  120. Gilead Sciences
  121. Gland Pharma
  122. GlaxoSmithKline
  123. Glenmark Pharmaceuticals
  124. Grifols Therapeutics
  125. H K Zion Industry
  126. Hanmi Pharmaceutical
  127. Harbour BioMed
  128. Healthcare Pharmaceuticals
  129. Heptares Therapeutics
  130. Heron Therapeutics
  131. Hetero Drugs
  132. HK Surgical
  133. Hoffmann-La Roche
  134. Institut Biochimique
  135. IDT Biologika
  136. IlYang Pharmaceuticals
  137. ImmuneMed
  138. ImmunityBio
  139. Inhibrx
  140. Injecto
  141. Inmunotek 
  142. Innovent Biologics
  143. Intas Pharmaceuticals
  144. Intra-Cellular Therapies
  145. Ipsen
  146. IQVIA
  147. Italfarmaco
  148. Jain Rubbers
  149. Janssen Pharmaceuticals
  150. JCR Pharmaceuticals
  151. Jiangsu HengRui Medicine
  152. Jiangsu Hualan New Pharmaceutical Material
  153. Jiangxi Qingfeng Pharmaceutical    
  154. Jiangyin Hongmeng Rubber Plastic Product
  155. Johnson & Johnson
  156. Kastle Therapeutics
  157. Kemwell Biopharma
  158. Keymed Biosciences
  159. Kiniksa Pharmaceuticals
  160. Kitasato Daiichi Sankyo Vaccine
  161. Kymab (Acquired by Sanofi)
  162. Kyowa Hakko Kirin
  163. Labcorp
  164. Laboratoire AGUETTANT
  165. Salvat Laboratories 
  166. LEO Pharma
  167. Lundbeck
  168. Luye Pharma Group
  169. Lyophilization Services of New England (LSNE)
  170. Mapi Pharma
  171. Maruishi Pharmaceutical
  172. Medicago
  173. Medicalchain
  174. Medline
  175. Medica Scientia Innovation Research (MEDSIR)
  176. Megalabs
  177. Merck
  178. Millennium Pharmaceuticals
  179. Mitsubishi Gas Chemical
  180. Momenta Pharmaceuticals
  181. MorphoSys
  182. Mylan
  183. Nanexa
  184. Nektar Therapeutics
  185. NeuroDerm
  186. Nexus Pharmaceuticals
  187. Ningbo Zhengli Pharmaceutical Packaging
  188. Nippon Organon
  189. Nipro PharmaPackaging
  190. Novartis
  191. Novo Nordisk
  192. Octapharma
  193. Oncorus
  194. Otsuka Pharmaceutical
  195. Outlook Therapeutics
  196. PapiVax Biotech
  197. PCI Pharma Services
  198. Paige Biopharmaceutical
  199. Peptron
  200. Pfizer
  201. PharmaEssentia  
  202. PHC Injection Device Technologies
  203. Piramal Pharma
  204. Pisa Farmaceutica
  205. Plas-Tech Engineering
  206. Pluristem Therapeutics
  207. Polpharma Biologics
  208. Primequal
  209. Propella Therapeutics
  210. PTC Therapeutics
  211. Qindao Huaren Medical
  212. RAUMEDIC
  213. Regeneron
  214. Rejuven Dermaceutical
  215. Reliance Life Sciences
  216. Rentschler Biopharma
  217. RHEACELL  
  218. Roche
  219. Laboratorios Farmaceuticos Rovi 
  220. R-Pharm
  221. Sagar Rubber Products
  222. Samsung Bioepis
  223. Samsung BioLogics
  224. Samsung Medical Rubber
  225. Sandoz
  226. Sanofi
  227. Scancell
  228. SCHOTT
  229. SciPharm
  230. Secura Bio
  231. Seqirus
  232. Serina Therapeutics
  233. Serum Institute of India
  234. Sewa Medicals
  235. Shan Dong Boan Biotechnology (Acquired by Luye Pharma)
  236. Shandong Jihai Medical Technology
  237. Shandong Pharmaceutical Glass
  238. Shandong Weigao
  239. Shandong Zibo Minkang Pharmaceutical Packaging
  240. Shanghai Hengrui Pharmaceutical
  241. Sheng Zou Rubber & Plastics
  242. Shin Yan Sheno Precision Industrial
  243. Shire
  244. Shrinath Products (A Divison of Elmer Products)
  245. Siegfried Holding
  246. Splash Pharmaceuticals
  247. Square Pharmaceuticals
  248. SRI International
  249. SRK Pharmaceuticals
  250. STADA Arzneimittel
  251. Stealth BioTherapeutics
  252. Sumitomo Rubber Industries
  253. Sun Pharmaceutical Industries
  254. Sunshine Guojian
  255. Surecare Pharma
  256. Swedish Orphan Biovitrum
  257. Taizhou Kanglong Pharmaceutical Packing
  258. TaiMed Biologics
  259. Taisei Kako
  260. Taj Life Sciences
  261. Taj Pharmaceuticals
  262. Takeda
  263. Talecris Biotherapeutics
  264. Terumo
  265. Tetherex Pharmaceuticals  
  266. Teva Pharmaceuticals
  267. The Plasticoid Company
  268. Tip-Top
  269. Tolmar
  270. Toray Industries
  271. Transcoject
  272. Trinomab Biotech 
  273. UCB Biopharma
  274. Closed Joint Stock Company (CJSC) Unimed Laboratories
  275. United BioPharma
  276. Universal Medicap
  277. US WorldMeds
  278. Vetter Pharma
  279. VHB Medi Sciences
  280. Vighnesh Rubbers
  281. ViiV Healthcare
  282. VITARIS
  283. Weidmann Medical Technology
  284. West Pharmaceutical
  285. WuXi Biologics
  286. Xbiotech
  287. Xencor
  288. Xeris Biopharma
  289. YL Biologics
  290. Yuhan  
  291. Zealand Pharma
  292. Zen Pharma

PRICING DETAILS

USD 5,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com